1
|
Lv T, Xie C, Zhang Y, Liu Y, Zhang G, Qu B, Zhao W, Xu S. A qualitative study of improving megavoltage computed tomography image quality and maintaining dose accuracy using cycleGAN-based image synthesis. Med Phys 2024; 51:394-406. [PMID: 37475544 DOI: 10.1002/mp.16633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2022] [Revised: 06/18/2023] [Accepted: 07/02/2023] [Indexed: 07/22/2023] Open
Abstract
BACKGROUND Due to inconsistent positioning, tumor shrinking, and weight loss during fractionated treatment, the initial plan was no longer appropriate after a few fractional treatments, and the patient will require adaptive helical tomotherapy (HT) to overcome the issue. Patients are scanned with megavoltage computed tomography (MVCT) before each fractional treatment, which is utilized for patient setup and provides information for dose reconstruction. However, the low contrast and high noise of MVCT make it challenging to delineate treatment targets and organs at risk (OAR). PURPOSE This study developed a deep-learning-based approach to generate high-quality synthetic kilovoltage computed tomography (skVCT) from MVCT and meet clinical dose requirements. METHODS Data from 41 head and neck cancer patients were collected; 25 (2995 slices) were used for training, and 16 (1898 slices) for testing. A cycle generative adversarial network (cycleGAN) based on attention gate and residual blocks was used to generate MVCT-based skVCT. For the 16 patients, kVCT-based plans were transferred to skVCT images and electron density profile-corrected MVCT images to recalculate the dose. The quantitative indices and clinically relevant dosimetric metrics, including the mean absolute error (MAE), structural similarity index measure (SSIM), peak signal-to-noise ratio (PSNR), gamma passing rates, and dose-volume-histogram (DVH) parameters (Dmax , Dmean , Dmin ), were used to assess the skVCT images. RESULTS The MAE, PSNR, and SSIM of MVCT were 109.6 ± 12.3 HU, 27.5 ± 1.1 dB, and 91.9% ± 1.7%, respectively, while those of skVCT were 60.6 ± 9.0 HU, 34.0 ± 1.9 dB, and 96.5% ± 1.1%. The image quality and contrast were enhanced, and the noise was reduced. The gamma passing rates improved from 98.31% ± 1.11% to 99.71% ± 0.20% (2 mm/2%) and 99.77% ± 0.18% to 99.98% ± 0.02% (3 mm/3%). No significant differences (p > 0.05) were observed in DVH parameters between kVCT and skVCT. CONCLUSION With training on a small data set (2995 slices), the model successfully generated skVCT with improved image quality, and the dose calculation accuracy was similar to that of MVCT. MVCT-based skVCT can increase treatment accuracy and offer the possibility of implementing adaptive radiotherapy.
Collapse
Affiliation(s)
- Tie Lv
- Beihang University, School of Physics, Beijing, China
- The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China
| | - Chuanbin Xie
- Beihang University, School of Physics, Beijing, China
- The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China
| | - Yihang Zhang
- Beihang University, School of Physics, Beijing, China
- The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China
| | - Yaoying Liu
- Beihang University, School of Physics, Beijing, China
- The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China
| | - Gaolong Zhang
- Beihang University, School of Physics, Beijing, China
| | - Baolin Qu
- The First Medical Center of PLA General Hospital, Department of Radiation Oncology, Beijing, China
| | - Wei Zhao
- Beihang University, School of Physics, Beijing, China
| | - Shouping Xu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
2
|
Zhang Y, Rong L, Wang Z, Zhao H. The top 100 most cited articles in helical tomotherapy: a scoping review. Front Oncol 2023; 13:1274290. [PMID: 37916164 PMCID: PMC10616822 DOI: 10.3389/fonc.2023.1274290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 10/03/2023] [Indexed: 11/03/2023] Open
Abstract
Objective The purpose of this scoping review was to explore the top 100 most cited articles in helical tomotherapy (HT) through bibliometric analysis and visualization tools, help researchers comprehensively understand the research hotspots of HT, and provide clear and intuitive network visualization. Methods The Web of Science Core Collection and the search strategy of "Title (TI)=(tomotherapy)" were used to search for articles related to HT as of 27 May 2023. The top 100 most cited articles were obtained by sorting "citations: highest first". From these top 100 most cited articles, the following information was extracted: journals, years and months, countries, authors, types of tumor treated, and topics. The VOSviewer software was introduced for visualizing all the articles related to HT. Results The top 100 most cited articles in HT were published between 1999 and 2019. The citation counts of these articles ranges from 326 to 45, with a total of 8,422 citations at the time of searching. The index of citations per year (CPY) ranges from 22.32 to 2.45. These articles originated from 17 countries, with most publications from the United States (n=50), followed by Canada (n=12), Italy (n=10), Germany (n=7) and Belgium (n=5). The International Journal of Radiation Oncology, Biology, Physics published the highest number of articles (n=31), followed by Radiotherapy and Oncology (n=20), Medical Physics (n=13) and Strahlentherapie und Onkologie (n=12). In terms of specific tumor types, head and neck cancer (n=15) is the most common disease, followed by cancers with complex target structures (n=14), breast cancer (n=12), prostate cancer (n=10) and lung cancer (n=8). The most common research topics also include dosimetric comparison (n = 44), quality assurance (n = 12) and Megavoltage CT (n = 8). Conclusion This scoping review provides a comprehensive list of the 100 most cited articles in HT. This analysis offers valuable insights into the current research directions of HT that can be utilized by researchers, clinicians, and policy-makers.
Collapse
Affiliation(s)
| | | | | | - Hongfu Zhao
- Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun, China
| |
Collapse
|
3
|
Quispe-Huillcara B, de-la-Rosa KM, Reyes U, Cerón PV, Vega HR, Sosa MA. Characterization of the radiation beam of a tomotherapy equipment with MCNP. Appl Radiat Isot 2023; 200:110978. [PMID: 37603966 DOI: 10.1016/j.apradiso.2023.110978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 07/18/2023] [Accepted: 08/08/2023] [Indexed: 08/23/2023]
Abstract
This work aims to model and characterize the radiation beam of one Accuray tomotherapy equipment using the Monte Carlo Code MCNP5 (Monte Carlo N-Particle). This tomotherapy equipment is used for delivering high doses of radiation in tumor regions to kill cancer cells and shrink the tumor during radiation therapy of cancer patients, however, the radiation can damage surrounding areas and nearby organs at risk (OAR) if the radiation field is not well delimited. In particular, intensity-modulated radiotherapy treatments (IMRT) with tomotherapy equipment offer great benefits to patients allowing treatment of tumor regions without affecting surrounding areas and OAR. Nowadays, it is well known that a correct simulation of transport of radiation in tomotherapy equipment facilitates considerably the estimation of ideal doses in the tumor, surrounding regions, and OAR. For that reason, in this work, we simulated the geometry of the 6 MV ACCURAY Tomotherapy equipment of the CECAN using the MCNP5. The model includes a TomoLINAC consisting of an electron source that emits Gaussian distribution particles with an average energy of 5.7 MeV and width of 0.3 MeV. The emitted particles impact the tungsten target and pass through primary collimators and jaws that define the irradiation field in the isocenter. To validate the geometry and radiation transport in the TomoLINAC the curves of depth dose percentage (PDD) estimated by simulation and the curves measured experimentally were tuned. In the same way, the simulated transverse and longitudinal profiles were compared with the experimental results. In addition, a comparison between the qualities of the radiation beam characterized with MCNP and measured experimentally in CECAN showed a deviation of 1%. For the simulations, cylindrical detectors located inside a water phantom were considered and it was employed the tally *F8. A good agreement was observed between the PDD's curves obtained from the simulation and those measured experimentally for a field of 5 × 10 cm2 in the isocenter and SSD (distance from the source to the surface) of 85 cm. Also, the comparison between the simulated and experimental transverse profiles obtained at 1.5 cm, 10 cm and 15 cm depth with a radiation field of 5 × 40 cm2 showed very good agreement. The longitudinal profiles were estimated with the same depths as the transverse ones, but for each of them, the openings of the jaws were 5.0 cm, 2.5 cm and 1.0 cm in the longitudinal direction, which corresponds to the direction in which the patient's table moves. The comparison between the simulated and experimental longitudinal profiles showed good concordance too. Once the radiation beam of the ACCURAY tomotherapy equipment had been characterized, experimental dose measurements were made using a Cheese phantom and two A1SL ionization chambers. These results obtained experimentally were compared with those estimated with MCNP for a field of 5 × 40 cm2 at the isocenter and SAD of 85 cm and, it was concluded that both results were similar considering the regions of uncertainty. Finally, we must highlight that the modeling and characterization of the radiation beam of CECAN's ACCURAY tomotherapy equipment can be a key tool for dose estimations in different cancer treatment plans and future research.
Collapse
Affiliation(s)
| | | | - Uvaldo Reyes
- State Center of Cancerology, Durango Health Services, 34000, Durango, Dgo., Mexico
| | - Pablo V Cerón
- Department of Environmental Sciences, DCIyT, University of Quintana Roo, 77019, Chetumal, QRoo, Mexico
| | - Héctor R Vega
- Academic Unit of Nuclear Studies, Autonomous University of Zacatecas, 98000, Zacatecas, Zac., Mexico
| | - Modesto A Sosa
- Department of Physical Engineering, DCI, University of Guanajuato, 37150, Leon, Gto., Mexico.
| |
Collapse
|
4
|
Ji X, Jiang W, Wang J, Zhou B, Ding W, Liu S, Huang H, Chen G, Sun X. Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors. Front Immunol 2023; 13:1106644. [PMID: 36713375 PMCID: PMC9877461 DOI: 10.3389/fimmu.2022.1106644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Accepted: 12/22/2022] [Indexed: 01/14/2023] Open
Abstract
Radiotherapy is one of the mainstays of cancer treatment. More than half of cancer patients receive radiation therapy. In addition to the well-known direct tumoricidal effect, radiotherapy has immunomodulatory properties. When combined with immunotherapy, radiotherapy, especially high-dose radiotherapy (HDRT), exert superior systemic effects on distal and unirradiated tumors, which is called abscopal effect. However, these effects are not always effective for cancer patients. Therefore, many studies have focused on exploring the optimized radiotherapy regimens to further enhance the antitumor immunity of HDRT and reduce its immunosuppressive effect. Several studies have shown that low-dose radiotherapy (LDRT) can effectively reprogram the tumor microenvironment, thereby potentially overcoming the immunosuppressive stroma induced by HDRT. However, bridging the gap between preclinical commitment and effective clinical delivery is challenging. In this review, we summarized the existing studies supporting the combined use of HDRT and LDRT to synergistically enhance antitumor immunity, and provided ideas for the individualized clinical application of multimodal radiotherapy (HDRT+LDRT) combined with immunotherapy.
Collapse
|
5
|
Paoletti L, Ceccarelli C, Menichelli C, Aristei C, Borghesi S, Tucci E, Bastiani P, Cozzi S. Special stereotactic radiotherapy techniques: procedures and equipment for treatment simulation and dose delivery. Rep Pract Oncol Radiother 2022; 27:1-9. [PMID: 35402024 PMCID: PMC8989452 DOI: 10.5603/rpor.a2021.0129] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 11/14/2021] [Indexed: 12/25/2022] Open
Abstract
Stereotactic radiotherapy (SRT ) is a multi-step procedure with each step requiring extreme accuracy. Physician-dependent accuracy includes appropriate disease staging, multi-disciplinary discussion with shared decision-making, choice of morphological and functional imaging methods to identify and delineate the tumor target and organs at risk, an image-guided patient set-up, active or passive management of intra-fraction movement, clinical and instrumental follow-up. Medical physicist-dependent accuracy includes use of advanced software for treatment planning and more advanced Quality Assurance procedures than required for conventional radiotherapy. Consequently, all the professionals require appropriate training in skills for high-quality SRT. Thanks to the technological advances, SRT has moved from a “frame-based” technique, i.e. the use of stereotactic coordinates which are identified by means of rigid localization frames, to the modern “frame-less” SRT which localizes the target volume directly, or by means of anatomical surrogates or fiducial markers that have previously been placed within or near the target. This review describes all the SRT steps in depth, from target simulation and delineation procedures to treatment delivery and image-guided radiation therapy. Target movement assessment and management are also described.
Collapse
Affiliation(s)
- Lisa Paoletti
- Radiotherapy Unit, AUSL Toscana Centro, Florence, Italy
| | | | | | - Cynthia Aristei
- Radiation Oncology Section, University of Perugia and Perugia General Hospital, Italy
| | - Simona Borghesi
- Radiation Oncology Unit of Arezzo-Valdarno, Azienda USL Toscana Sud Est, Italy
| | - Enrico Tucci
- Radiation Oncology Unit of Arezzo-Valdarno, Azienda USL Toscana Sud Est, Italy
| | | | - Salvatore Cozzi
- Radiation Oncology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Italy
| |
Collapse
|
6
|
Lee D, Jeong SW, Kim SJ, Cho H, Park W, Han Y. Improvement of megavoltage computed tomography image quality for adaptive helical tomotherapy using cycleGAN-based image synthesis with small datasets. Med Phys 2021; 48:5593-5610. [PMID: 34418109 DOI: 10.1002/mp.15182] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Revised: 07/20/2021] [Accepted: 07/30/2021] [Indexed: 11/07/2022] Open
Abstract
PURPOSE Megavoltage computed tomography (MVCT) offers an opportunity for adaptive helical tomotherapy. However, high noise and reduced contrast in the MVCT images due to a decrease in the imaging dose to patients limits its usability. Therefore, we propose an algorithm to improve the image quality of MVCT. METHODS The proposed algorithm generates kilovoltage CT (kVCT)-like images from MVCT images using a cycle-consistency generative adversarial network (cycleGAN)-based image synthesis model. Data augmentation using an affine transformation was applied to the training data to overcome the lack of data diversity in the network training. The mean absolute error (MAE), root-mean-square error (RMSE), peak signal-to-noise ratio (PSNR), and structural similarity index measure (SSIM) were used to quantify the correction accuracy of the images generated by the proposed algorithm. The proposed method was validated by comparing the images generated with those obtained from conventional and deep learning-based image processing method through non-augmented datasets. RESULTS The average MAE, RMSE, PSNR, and SSIM values were 18.91 HU, 69.35 HU, 32.73 dB, and 95.48 using the proposed method, respectively, whereas cycleGAN with non-augmented data showed inferior results (19.88 HU, 70.55 HU, 32.62 dB, 95.19, respectively). The voxel values of the image obtained by the proposed method also indicated similar distributions to those of the kVCT image. The dose-volume histogram of the proposed method was also similar to that of electron density corrected MVCT. CONCLUSIONS The proposed algorithm generates synthetic kVCT images from MVCT images using cycleGAN with small patient datasets. The image quality achieved by the proposed method was correspondingly improved to the level of a kVCT image while maintaining the anatomical structure of an MVCT image. The evaluation of dosimetric effectiveness of the proposed method indicates the applicability of accurate treatment planning in adaptive radiation therapy.
Collapse
Affiliation(s)
- Dongyeon Lee
- Department of Radiation Convergence Engineering, Yonsei University, Wonju, Republic of Korea.,Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea
| | - Sang Woon Jeong
- Department of Health Sciences and Technology, SAIHST,Sungkyunkwan University, Seoul, Republic of Korea.,Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea
| | - Sung Jin Kim
- Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea
| | - Hyosung Cho
- Department of Radiation Convergence Engineering, Yonsei University, Wonju, Republic of Korea
| | - Won Park
- Department of Health Sciences and Technology, SAIHST,Sungkyunkwan University, Seoul, Republic of Korea.,Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea
| | - Youngyih Han
- Department of Health Sciences and Technology, SAIHST,Sungkyunkwan University, Seoul, Republic of Korea.,Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea
| |
Collapse
|
7
|
Kinhikar R, Kaushik S, Tambe C, Kadam S, Kale S, Upreti R. Implementation and Challenges of International Atomic Energy Agency/American Association of Physicists in Medicine TRS 483 Formalism for Field Output Factors and Involved Uncertainties Determination in Small Fields for TomoTherapy. J Med Phys 2021; 46:162-170. [PMID: 34703100 PMCID: PMC8491308 DOI: 10.4103/jmp.jmp_11_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 05/28/2021] [Accepted: 06/01/2021] [Indexed: 11/04/2022] Open
Abstract
PURPOSE International Atomic Energy Agency published TRS-483 to address the issues of small field dosimetry. Our study calculates the output factor in the small fields of TomoTherapy using different detectors and dosimetric conditions. Furthermore, it estimates the various components of uncertainty and presents challenges faced during implementation. MATERIALS AND METHODS Beam quality TPR20,10(10) at the hypothetical field size of 10 cm × 10 cm was calculated from TPR20,10(S). Two ionization chambers based on the minimum field width required to satisfy the lateral charge particle equilibrium and one unshielded electron field diode (EFD) were selected. Output factor measurements were performed in various dosimetric conditions. RESULTS Beam quality TPR20,10(10) has a mean value of 0.627 ± 0.001. The maximum variation of output factor between CC01 chamber and EFD diode at the smallest field size was 11.80%. In source to surface setup, the difference between water and virtual water was up to 9.68% and 8.13%, respectively, for the CC01 chamber and EFD diode. The total uncertainty in the ionization chamber was 2.43 times higher compared to the unshielded EFD diode at the smallest field size. CONCLUSIONS Beam quality measurements, chamber selection procedure, and output factors were successfully carried out. A difference of up to 10% in output factor can occur if density scaling for electron density in virtual water is not considered. The uncertainty in output correction factors dominates, while positional and meter reading uncertainty makes a minor contribution to total uncertainty. An unshielded EFD diode is a preferred detector in small fields because of lower uncertainty in measurements compared to ionization chambers.
Collapse
Affiliation(s)
- Rajesh Kinhikar
- Department of Medical Physics, Tata Memorial Centre, Parel, Mumbai, India
- Homi Bhabha National Institute, Anushaktinagar, Mumbai, Maharashtra, India
| | - Suryakant Kaushik
- Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre Kharghar, Navi Mumbai, Maharashtra, India
| | | | - Sudarshan Kadam
- Department of Medical Physics, Tata Memorial Centre, Parel, Mumbai, India
| | - Shrikant Kale
- Department of Medical Physics, Tata Memorial Centre, Parel, Mumbai, India
| | - Rituraj Upreti
- Department of Medical Physics, Tata Memorial Centre, Parel, Mumbai, India
- Homi Bhabha National Institute, Anushaktinagar, Mumbai, Maharashtra, India
| |
Collapse
|
8
|
Colnot J, Zefkili S, Gschwind R, Huet C. Out-of-field doses from radiotherapy using photon beams: A comparative study for a pediatric renal treatment. J Appl Clin Med Phys 2021; 22:94-106. [PMID: 33547766 PMCID: PMC7984471 DOI: 10.1002/acm2.13182] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 12/20/2020] [Accepted: 01/06/2021] [Indexed: 12/04/2022] Open
Abstract
PURPOSE First, this experimental study aims at comparing out-of-field doses delivered by three radiotherapy techniques (3DCRT, VMAT (two different accelerators), and tomotherapy) for a pediatric renal treatment. Secondly, the accuracy of treatment planning systems (TPS) for out-of-field calculation is evaluated. METHODS EBT3 films were positioned in pediatric phantoms (5 and 10 yr old). They were irradiated according to four plans: 3DCRT (Clinac 2100CS, Varian), VMAT (Clinac 2100CS and Halcyon, Varian), and tomotherapy for a same target volume. 3D dose determination was performed with an in-house Matlab tool using linear interpolation of film measurements. 1D and 3D comparisons were made between techniques. Finally, measurements were compared to the Eclipse (Varian) and Tomotherapy (Accuray) TPS calculations. RESULTS Advanced radiotherapy techniques (VMATs and tomotherapy) deliver higher out-of-field doses compared to 3DCRT due to increased beam-on time triggered by intensity modulation. Differences increase with distance to target and reach a factor of 3 between VMAT and 3DCRT. Besides, tomotherapy delivers lower doses than VMAT: although tomotherapy beam-on time is higher than in VMAT, the additional shielding of the Hi-Art system reduces out-of-field doses. The latest generation Halcyon system proves to deliver lower peripheral doses than conventional accelerators. Regarding TPS calculation, tomotherapy proves to be suitable for out-of-field dose determination up to 30 cm from field edge whereas Eclipse (AAA and AXB) largely underestimates those doses. CONCLUSION This study shows that the high dose conformation allowed by advanced radiotherapy is done at the cost of higher peripheral doses. In the context of treatment-related risk estimation, the consequence of this increase might be significative. Modern systems require adapted head shielding and a particular attention has to be taken regarding on-board imaging dose. Finally, TPS advanced dose calculation algorithms do not certify dose accuracy beyond field edges, and thus, those doses are not suitable for risk assessment.
Collapse
Affiliation(s)
- Julie Colnot
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Service de Recherche en Dosimétrie, Laboratoire de Dosimétrie des Rayonnements Ionisants, Fontenay-aux-Roses, France
| | - Sofia Zefkili
- Institut Curie, Service de Physique Médicale, Paris, France
| | - Régine Gschwind
- Université de Bourgogne-Franche-Comté, LCE UMR 6249, Montbéliard, France
| | - Christelle Huet
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Service de Recherche en Dosimétrie, Laboratoire de Dosimétrie des Rayonnements Ionisants, Fontenay-aux-Roses, France
| |
Collapse
|
9
|
Bouchard H. Reference dosimetry of modulated and dynamic photon beams. Phys Med Biol 2021; 65:24TR05. [PMID: 33438582 DOI: 10.1088/1361-6560/abc3fb] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In the late 1980s, a new technique was proposed that would revolutionize radiotherapy. Now referred to as intensity-modulated radiotherapy, it is at the core of state-of-the-art photon beam delivery techniques, such as helical tomotherapy and volumetric modulated arc therapy. Despite over two decades of clinical application, there are still no established guidelines on the calibration of dynamic modulated photon beams. In 2008, the IAEA-AAPM work group on nonstandard photon beam dosimetry published a formalism to support the development of a new generation of protocols applicable to nonstandard beam reference dosimetry (Alfonso et al 2008 Med. Phys. 35 5179-86). The recent IAEA Code of Practice TRS-483 was published as a result of this initiative and addresses exclusively small static beams. But the plan-class specific reference calibration route proposed by Alfonso et al (2008 Med. Phys. 35 5179-86) is a change of paradigm that is yet to be implemented in radiotherapy clinics. The main goals of this paper are to provide a literature review on the dosimetry of nonstandard photon beams, including dynamic deliveries, and to discuss anticipated benefits and challenges in a future implementation of the IAEA-AAPM formalism on dynamic photon beams.
Collapse
Affiliation(s)
- Hugo Bouchard
- Département de physique, Université de Montréal, Complexe des sciences, 1375 Avenue Thérèse-Lavoie-Roux, Montréal, Québec H2V 0B3, Canada. Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 Rue Saint-Denis, Montréal, Québec H2X 0A9, Canada. Département de radio-oncologie, Centre hospitalier de l'Université de Montréal (CHUM), 1051 Rue Sanguinet, Montréal, Québec H2X 3E4, Canada
| |
Collapse
|
10
|
Sudhyadhom A. On the molecular relationship between Hounsfield Unit (HU), mass density, and electron density in computed tomography (CT). PLoS One 2020; 15:e0244861. [PMID: 33382794 PMCID: PMC7775093 DOI: 10.1371/journal.pone.0244861] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Accepted: 12/17/2020] [Indexed: 11/19/2022] Open
Abstract
Accurate determination of physical/mass and electron densities are critical to accurate spatial and dosimetric delivery of radiotherapy for photon and charged particles. In this manuscript, the biology, chemistry, and physics that underly the relationship between computed tomography (CT) Hounsfield Unit (HU), mass density, and electron density was explored. In standard radiation physics practice, quantities such as mass and electron density are typically calculated based off a single kilovoltage CT (kVCT) scan assuming a one-to-one relationship between HU and density. It is shown that, in absence of mass density assumptions on tissues, the relationship between HU and density is not one-to-one with uncertainties as large as 7%. To mitigate this uncertainty, a novel multi-dimensional theoretical approach is defined between molecular (water, lipid, protein, and mineral) composition, HU, mass density, and electron density. Empirical parameters defining this relationship are x-ray beam energy/spectrum dependent and, in this study, two methods are proposed to solve for them including through a tissue mimicking phantom calibration process. As a proof of concept, this methodology was implemented in a separate in-house created tissue mimicking phantom and it is shown that sub 1% accuracy is possible for both mass and electron density. As molecular composition is not always known, the sensitivity of this model to uncertainties in molecular composition was investigated and it was found that, for soft tissue, sub 1% accuracy is achievable assuming nominal organ/tissue compositions. For boney tissues, the uncertainty in mineral content may lead to larger errors in mass and electron density compared with soft tissue. In this manuscript, a novel methodology to directly determine mass and electron density based off CT HU and knowledge of molecular compositions is presented. If used in conjunction with a methodology to determine molecular compositions, mass and electron density can be accurately calculated from CT HU.
Collapse
Affiliation(s)
- Atchar Sudhyadhom
- Brigham & Women’s Hospital, Boston, MA, United States of America
- Dana Farber Cancer Institute, Boston, MA, United States of America
- Harvard Medical School, Boston, MA, United States of America
- University of California, San Francisco, San Francisco, CA, United States of America
| |
Collapse
|
11
|
Akbaba S, Bostel T, Lang K, Bahadir S, Lipman D, Schmidberger H, Matthias C, Rotter N, Knopf A, Freudlsperger C, Plinkert P, Debus J, Adeberg S. Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands. Front Oncol 2020; 10:593379. [PMID: 33262950 PMCID: PMC7686540 DOI: 10.3389/fonc.2020.593379] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Accepted: 10/19/2020] [Indexed: 11/13/2022] Open
Abstract
Introdution We aimed to evaluate treatment outcome of combined radiotherapy (RT) including photon intensity modulated radiotherapy (IMRT) and carbon ion boost for adenoid cystic carcinomas (ACCs) of the major salivary glands, the currently available largest German collective for this cohort. Materials and Methods Overall, 207 patients who were irradiated with combined RT between 2009 and 2019 at Heidelberg University Hospital were analyzed retrospectively for local control (LC), progression-free survival (PFS) and overall survival (OS) using Kaplan-Meier estimates. The majority of patients received postoperative RT (n=176/207, 85%) after previous surgery in large German hospitals mainly Mainz, Freiburg, Mannheim and Heidelberg University Hospitals and 15% received primary RT (n=31/207). Results After a median follow-up time of 50 months, 84% of the patients were still alive (n=174/207). Disease progression occurred in 32% of the patients (n=66/207) while local recurrence was diagnosed in 12% (n=25/207), and distant relapse in 27% (n=56/207). Estimated 5-year LC, PFS and OS rates were 84%, 56% and 83% for OS, respectively. In multivariate analysis, we could identify two prognostic subgroups: one subgroup resulting in decreased LC, PFS and OS rates and another subgroup having an additional survival disadvantage in PFS and OS. Patients with a macroscopic tumor disease (yes vs. no; p<0.001 for LC, p=0.010 for PFS and p=0.040 for OS) treated in a definitive setting (vs. postoperative setting; p=0.001 for LC, p=0.006 for PFS, p=0.049 for OS) and tumors of upper T stage (T1-4; p=0.004 for LC, p<0.001 for PFS, p<0.001 for OS) showed significantly more local relapses and a decreased PFS and OS. Upper Age (p<0.001 for both PFS and OS), lower Karnofsky Performance Score (<80% vs. ≥80%; p<0.001 for both PFS and OS) and solid histology (vs. non-solid; p=0.049 for PFS and p=0.003 for OS) were in addition associated with worse survival outcome. Toxicity was moderate with 18% late grade 2 and 3 toxicity. Conclusions Combined RT results in superior LC rates compared to photon data with moderate toxicity. In multivariate analysis, upper T stage, the existence of a macroscopic tumor before RT and definitive RT setting were identified as major prognostic factors affecting LC negatively.
Collapse
Affiliation(s)
- Sati Akbaba
- Department of Radiation Oncology, University Medical Center Mainz, Mainz, Germany.,Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
| | - Tilman Bostel
- Department of Radiation Oncology, University Medical Center Mainz, Mainz, Germany
| | - Kristin Lang
- Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
| | - Suzan Bahadir
- Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany.,Department of Radiology, Koru Hospitals-Yuksek Ihtisas University, Ankara, Turkey
| | - Djoeri Lipman
- Department of Radiation Oncology, Isala Hospital Zwolle, Zwolle, Netherlands
| | - Heinz Schmidberger
- Department of Radiation Oncology, University Medical Center Mainz, Mainz, Germany
| | - Christoph Matthias
- Department of Laryngology and Head and Neck Surgery, University Medical Center Mainz, Mainz, Germany
| | - Nicole Rotter
- Department of Laryngology and Head and Neck Surgery, University Hospital Mannheim, Mannheim, Germany
| | - Andreas Knopf
- Department of Laryngology and Head and Neck Surgery, University Hospital Freiburg, Freiburg im Breisgau, Germany
| | - Christian Freudlsperger
- Department of Oral and Maxillofacial Surgery, University Hospital Heidelberg, Heidelberg, Germany
| | - Peter Plinkert
- Department of Laryngology and Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany
| | - Juergen Debus
- Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
| | - Sebastian Adeberg
- Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
| |
Collapse
|
12
|
Santos T, Ventura T, Mateus J, Capela M, Lopes MDC. On the complexity of helical tomotherapy treatment plans. J Appl Clin Med Phys 2020; 21:107-118. [PMID: 32363800 PMCID: PMC7386195 DOI: 10.1002/acm2.12895] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 04/09/2020] [Accepted: 04/13/2020] [Indexed: 11/08/2022] Open
Abstract
PURPOSE Multiple metrics are proposed to characterize and compare the complexity of helical tomotherapy (HT) plans created for different treatment sites. METHODS A cohort composed of 208 HT plans from head and neck (105), prostate (51) and brain (52) tumor sites was considered. For each plan, 14 complexity metrics were calculated. Those metrics evaluate the percentage of leaves with small opening times or approaching the projection duration, the percentage of closed leaves, the amount of tongue-and-groove effect, and the overall modulation of the planned sinogram. To enable data visualization, an approach based on principal component analysis was followed to reduce the dataset dimensionality. This allowed the calculation of a global plan complexity score. The correlation between plan complexity and pretreatment verification results using the Spearman's rank correlation coefficients was investigated. RESULTS According to the global score, the most complex plans were the head and neck tumor cases, followed by the prostate and brain lesions irradiated with stereotactic technique. For almost all individual metrics, head and neck plans confirmed to be the plans with the highest complexity. Nevertheless, prostate cases had the highest percentage of leaves with an opening time approaching the projection duration, whereas the stereotactic brain plans had the highest percentage of closed leaves per projection. Significant correlations between some of the metrics and the pretreatment verification results were identified for the stereotactic brain group. CONCLUSIONS The proposed metrics and the global score demonstrated to be useful to characterize and quantify the complexity of HT plans of different treatment sites. The reported differences inter- and intra-group may be valuable to guide the planning process aiming at reducing uncertainties and harmonize planning strategies.
Collapse
Affiliation(s)
- Tania Santos
- Physics Department, University of Coimbra, Coimbra, Portugal.,Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Tiago Ventura
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Josefina Mateus
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Miguel Capela
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | | |
Collapse
|
13
|
Panda S, Swamidas J, Chopra S, Mangaj A, Fogliata A, Kupelian P, Agarwal JP, Cozzi L. Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri. Radiat Oncol 2020; 15:22. [PMID: 32000832 PMCID: PMC6990476 DOI: 10.1186/s13014-020-1473-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2019] [Accepted: 01/19/2020] [Indexed: 12/26/2022] Open
Abstract
Purpose To ascertain the dosimetric performance of a new delivery system (the Halcyon system, H) equipped with dual-layer stacked multi-leaf collimator (MLC) for risk-adapted targets in cervix uteri cancer patients compared to another ring-based system in clinical operation (Helical Tomotherapy, HT). Methods Twenty patients were retrospectively included in a treatment planning study (10 with positive lymph nodes and 10 without). The dose prescription (45Gy to the primary tumour volume and a simultaneously integrated boost up to 55Gy for the positive patients) and the clinical planning objectives were defined consistently as recommended by an ongoing multicentric clinical trial. Halcyon plans were optimised for the volumetric modulated arc therapy. The plan comparison was performed employing the quantitative analysis of the dose-volume histograms. Results The coverage of the primary and nodal target volumes was comparable for both techniques and both subsets of patients. The primary planning target volume (PTV) receiving at least 95% of the prescription isodose ranged from 97.2 ± 1.1% (node-negative) to 99.1 ± 1.2% (node-positive) for H and from 96.5 ± 1.9% (node-negative) to 98.3 ± 0.9% (node-positive) for HT. The uncertainty is expressed at one standard deviation from the cohort of patient per each group. For the nodal clinical target volumes, the dose received by 98% of the planning target volume ranged 55.5 ± 0.1 to 56.0 ± 0.8Gy for H and HT, respectively. The only significant and potentially relevant differences were observed for the bowels. In this case, V40Gy resulted 226.3 ± 35.9 and 186.9 ± 115.9 cm3 for the node-positive and node-negative patients respectively for Halcyon. The corresponding findings for HT were: 258.9 ± 60.5 and 224.9 ± 102.2 cm3. On the contrary, V15Gy resulted 1279.7 ± 296.5 and 1557.2 ± 359.9 cm3 for HT and H respectively for node-positive and 1010.8 ± 320.9 versus 1203.8 ± 332.8 cm3 for node-negative. Conclusion This retrospective treatment planning study, based on the dose constraints derived from the Embrace II study protocol, suggested the essential equivalence between Halcyon based and Helical Tomotherapy based plans for the intensity-modulated rotational treatment of cervix uteri cancer. Different levels of sparing were observed for the bowels with H better protecting in the high-dose region and HT in the mid-low dose regions. The clinical impact of these differences should be further addressed.
Collapse
Affiliation(s)
- S Panda
- Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India
| | - J Swamidas
- Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India
| | - S Chopra
- Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, Maharashtra, India
| | - A Mangaj
- Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India
| | - A Fogliata
- Humanitas Research Hospital, Radiotherapy and Cancer Center Radiosurgery Dept, Via Manzoni 56, 20089, Milan-Rozzano, Italy
| | - P Kupelian
- Varian Medical Systems, Palo Alto, CA, USA.,Radiation Oncology Dept., University of California, Los Angeles, USA
| | - J P Agarwal
- Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India
| | - L Cozzi
- Humanitas Research Hospital, Radiotherapy and Cancer Center Radiosurgery Dept, Via Manzoni 56, 20089, Milan-Rozzano, Italy. .,Dept. of Biomedical Sciences, Humanitas University, Milan-Rozzano, Italy.
| |
Collapse
|
14
|
Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience. Cancers (Basel) 2019; 11:cancers11111705. [PMID: 31683896 PMCID: PMC6895865 DOI: 10.3390/cancers11111705] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 10/28/2019] [Accepted: 10/29/2019] [Indexed: 01/25/2023] Open
Abstract
We aimed to evaluate the treatment outcome of primary and postoperative bimodal radiotherapy (RT) including intensity modulated photon radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) for sinonasal adenoid cystic carcinoma (ACC) patients. Medical records of 227 consecutive patients who received either a primary (n = 90, 40%) or postoperative (n = 137, 60%; R2, n = 86, 63%) IMRT with doses between 48 and 56 Gy in 1.8 or 2 Gy fractions and active raster-scanning carbon ion boost with 18 to 24 Gy (RBE, relative biological effectiveness) in 3 Gy (RBE) fractions between 2009 and 2019 up to a median total dose of 80 Gy (EQD2, equivalent dose in 2 Gy single dose fractions, range 71–80 Gy) were reviewed. Results: Median follow-up was 50 months. In univariate and multivariate analysis, no significant difference in local control (LC) could be shown between the two treatment groups (p = 0.33). Corresponding 3-year LC rates were 79% for primary bimodal RT and 82% for postoperative bimodal RT, respectively. T4 stage (p = 0.002) and solid histology (p = 0.005) were identified as independent prognostic factors for decreased LC. Significant worse long-term treatment tolerance was observed for postoperatively irradiated patients with 17% vs. 6% late grade 3 toxicity (p < 0.001). Primary radiotherapy including IMRT and carbon ion boost for dose-escalation results in adequate LC with less long-term grade 3 toxicity compared to postoperative bimodal radiotherapy in sinonasal ACC patients. The high rate of macroscopic tumor disease in the postoperative group makes the interpretation of the beneficial results in LC for primary RT difficult.
Collapse
|
15
|
The impact of the offset distance between the planning target volume and isocenter on irradiation time in TomoTherapy: A phantom study. Phys Med 2019; 63:19-24. [PMID: 31221404 DOI: 10.1016/j.ejmp.2019.05.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2018] [Revised: 04/19/2019] [Accepted: 05/18/2019] [Indexed: 11/23/2022] Open
Abstract
PURPOSE The influence of the offset distance from treatment target to gantry isocenter (GIC) on the dosimetric parameter and irradiation time was investigated using TomoTherapy METHODS: The reference position was defined as the centers of both the I'mRT phantom and planning target volume (PTV) with a spherical of 4 cm diameter aligned with the GIC. The dose calculations were performed in two offset methods with 2 and 12 Gy/fr, Method 1. The PTV was moved from 0.0 to 12.5 cm along the RL direction and -5.0 to 5.0 cm along the AP direction (PTV offset), Method 2. The phantom was moved from 0.0 to -7.5 cm along the RL direction and -5.0 to 5.0 cm along the AP direction (Phantom offset). The maximum, minimum and mean doses, homogeneity index, conformity index, irradiation time, and monitor unit were compared. RESULTS The irradiation times increased with increasing PTV offset. The increases in the irradiation time were 54.4% and 40.8% at PTV offsets of 12.5 cm along the RL direction for 2 and 12 Gy/fr, while the increases were 20.1% and 15.0% at a PTV offset of 5.0 cm along the AP direction. An increased irradiation time was not observed for the phantom offset. The offset didn't affect the other parameters. CONCLUSIONS The PTV location offset of ≥5 cm from the GIC along the RL and AP axes increased the irradiation time; therefore, the PTV should be aligned with the GIC as much as possible to reduce the irradiation time on TomoTherapy.
Collapse
|
16
|
Liu Y, Yue C, Zhu J, Yu H, Cheng Y, Yin Y, Li B, Dong J. A Megavoltage CT Image Enhancement Method for Image-Guided and Adaptive Helical TomoTherapy. Front Oncol 2019; 9:362. [PMID: 31134157 PMCID: PMC6524307 DOI: 10.3389/fonc.2019.00362] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2019] [Accepted: 04/18/2019] [Indexed: 01/08/2023] Open
Abstract
Purpose: To propose a novel method to improve the mega-voltage CT (MVCT) image quality for helical TomoTherapy while maintaining the stability on dose calculation. Materials and Methods: The Block-Matching 3D-transform (BM3D) and Discriminative Feature Representation (DFR) methods were combined into a novel BM3D + DFR method for their respective advantages. A phantom (Catphan504) and three serials of clinical (head & neck, chest, and pelvis) MVCT images from 30 patients were acquired using the helical TomoTherapy system. The contrast-to-noise ratio (CNR) and edge detection algorithm (canny) was employed for image quality comparisons between the original and BM3D + DFR enhanced MVCT. A simulated rectangular field of 6 MV X-ray beams were vertically delivered on the original and post-processed MVCT serials of the same CT density phantom, and the dose curves on both serials were compared to test the effects of image enhancement on dose calculation accuracy. Results: In total, 466 transversal MVCT slices were acquired and processed by both BM3D and the proposed BM3D + DFR methods. Compared to the original MVCT image, the BM3D + DFR method presented a remarkable improvement in terms of the soft tissue contrast and noise reduction. For the phantom image, the CNR of the region of interest (ROI) was improved from 1.70 to 4.03. The average CNR of ROIs for 10 patients from each anatomical group, were increased significantly from 1.45 ± 1.51 to 2.09 ± 1.68 for the head & neck (p < 0.001), from 0.92 ± 0.78 to 1.36 ± 0.85 for the chest (p < 0.001), and from 1.12 ± 1.22 to 1.76 ± 1.31 for the pelvis (p < 0.001), respectively. The canny edge detection operator showed that BM3D + DFR provided clearer organ boundaries with less chaos. The root-mean-square of the dosimetry difference on the iso-center passed horizontal dose profile curves and vertical percentage depth dose curves were only 0.09% and 0.06%, respectively. Conclusions: The proposed BM3D + DFR method is feasible to improve the soft tissue contrast for the original MVCT images with coincidence in dose calculation and without compromising resolution. After integration in clinical workflow, the post-processed MVCT may be better applied on image-guided and adaptive helical TomoTherapy.
Collapse
Affiliation(s)
- Yaru Liu
- Network-Based Intelligent Computing, University of Jinan, Jinan, China
| | - Chenxi Yue
- Network-Based Intelligent Computing, University of Jinan, Jinan, China
| | - Jian Zhu
- Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, China.,Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
| | - Haining Yu
- Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, China
| | - Yang Cheng
- Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, China
| | - Yong Yin
- Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, China
| | - Baosheng Li
- Department of Radiation Oncology, Shandong Cancer Hospital, Shandong University, Jinan, China
| | - Jiwen Dong
- Network-Based Intelligent Computing, University of Jinan, Jinan, China
| |
Collapse
|
17
|
Nagata H, Sugimoto S, Hongo H, Hashimoto H, Sato Y, Kawabata T, Watanabe H, Inoue T, Usui K, Kurokawa C, Sasai K. Patient organ doses from megavoltage computed tomography delivery with a helical tomotherapy unit using a general treatment planning system. JOURNAL OF RADIATION RESEARCH 2019; 60:401-411. [PMID: 30929023 PMCID: PMC6530616 DOI: 10.1093/jrr/rrz005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Revised: 10/19/2018] [Indexed: 06/09/2023]
Abstract
The purpose of this study was to quantify actual patient organ doses from megavoltage computed tomography (MVCT) using an MVCT beam model of a helical tomotherapy unit in a general treatment planning system (TPS). Dosimetric parameters (percentage depth dose, lateral beam profile, and longitudinal beam profile) of the MVCT beam were measured using Gafchromic EBT3 films (ISP Corporation, Wayne, NJ, USA) and used for beam modeling in a Pinnacle3 TPS (Philips, Amsterdam, Netherlands); this TPS is widely used with linear accelerators. The created beam model was adjusted and validated by assessing point doses in a cylindrical phantom in static and helical beam plans with fine, normal and coarse pitches. Maximum doses delivered to important organs from MVCT delivery for five clinical cases were calculated using the created beam model. The difference (average ± one standard deviation for all evaluation points) between calculated and measured doses was -0.69 ± 1.20% in the static beam plan. In the helical beam plan, the differences were 1.83 ± 2.65%, 1.35 ± 5.94% and -0.66 ± 8.48% for fine, normal and coarse pitches, respectively. The average maximum additional dose to important organs from MVCT in clinical cases was 0.82% of the prescribed dose. In conclusion, we investigated a method for quantifying patient organ dose from MVCT delivery on helical tomotherapy using an MVCT beam model in a general TPS. This technique enables estimation of the patient-specific organ dose from MVCT delivery, without the need for additional equipment.
Collapse
Affiliation(s)
- Hironori Nagata
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
- Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan
| | - Satoru Sugimoto
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Hideyuki Hongo
- Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan
| | - Harumitsu Hashimoto
- Department of Radiology, Shonan Fujisawa Tokusyukai Hospital, Fujisawa, Kanagawa, Japan
| | - Yuki Sato
- Technical Support Group, Radiation Therapy Technical Support Department, Hitachi, Ltd Healthcare Business Unit, Taito-ku, Tokyo, Japan
| | - Toru Kawabata
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Hiroyuki Watanabe
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Tatsuya Inoue
- Department of Radiology, Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan
| | - Keisuke Usui
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Chie Kurokawa
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Keisuke Sasai
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| |
Collapse
|
18
|
Kajaria A, Sharma N, Sharma S, Pradhan S, Mandal A, Aggarwal L. Monte Carlo Study of Unflattened Photon Beams Shaped by Multileaf Collimator. J Biomed Phys Eng 2019; 9:137-150. [PMID: 31214519 PMCID: PMC6538911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2016] [Accepted: 06/15/2016] [Indexed: 11/02/2022]
Abstract
INTRODUCTION This study investigates basic dosimetric properties of unflattened 6 MV photon beam shaped by multileaf collimator and compares them with those of flattened beams. MATERIALS AND METHODS Monte Carlo simulation model using BEAM code was developed for a 6MV photon beam based on Varian Clinic 600 unique performance linac operated with and without a flattening filter in beam line. Dosimetric features including lateral profiles, central axis depth dose, photon and electron spectra were calculated for flattened and unflattened cases, separately. RESULTS An increase in absolute depth dose with a factor of more than 2.4 was observed for unflattened beam which was dependent on depth. PDDs values were found to be lower for unflattened beam for all field sizes. Significant decrease in calculated mlc leakage was observed when the flattening filter was removed from the beam line. The total scatter factor, SCP was found to show less variation with field sizes for unflattened beam indicating a decrease in head scatter. The beam profiles for unflattened case are found to have lower relative dose value in comparison with flattened beam near the field edge, and it falls off faster with distance. CONCLUSION Our study showed that increase in the dose rate and lower peripheral dose could be considered as realistic advantages for unflattened 6MV photon beams.
Collapse
Affiliation(s)
- A. Kajaria
- School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP, India
| | - N. Sharma
- School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP, India
| | - Sh. Sharma
- School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP, India
| | - S. Pradhan
- Department of Radiotherapy and Radiation Medicine, Institute of Medical Science (BHU), Varanasi, UP, India
| | - A. Mandal
- Department of Radiotherapy and Radiation Medicine, Institute of Medical Science (BHU), Varanasi, UP, India
| | - L.M. Aggarwal
- Department of Radiotherapy and Radiation Medicine, Institute of Medical Science (BHU), Varanasi, UP, India
| |
Collapse
|
19
|
Aljabab S, Vellayappan B, Vandervoort E, Bahm J, Zohr R, Sinclair J, Caudrelier JM, Szanto J, Malone S. Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis. J Appl Clin Med Phys 2018; 19:160-167. [PMID: 29417728 PMCID: PMC5849852 DOI: 10.1002/acm2.12271] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 12/17/2017] [Accepted: 12/21/2017] [Indexed: 12/18/2022] Open
Abstract
PURPOSE The aim of this study is to compare the dosimetric differences between four techniques for spine stereotactic body radiotherapy (SBRT): CyberKnife (CK), volumetric modulated arc therapy (VMAT), and helical tomotherapy (HT) with dynamic jaws (HT-D) and fixed jaws (HT-F). MATERIALS/METHODS Data from 10 patients were utilized. All patients were planned for 24 Gy in two fractions, with the primary objectives being: (a) restricting the maximum dose to the cord to ≤ 17 Gy and/or cauda equina to ≤ 20 Gy, and (b) to maximize the clinical target volume (CTV) to receive the prescribed dose. Treatment plans were generated by separate dosimetrists and then compared using velocity AI. Parameters of comparison include target volume coverage, conformity index (CI), gradient index (GI), homogeneity index (HI), treatment time (TT) per fraction, and monitor units (MU) per fraction. RESULTS PTV D2 and D5 were significantly higher for CK compared to VMAT, HT-F, and HT-D (P < 0.001). The average volume of CTV receiving the prescription dose (CTV D95) was significantly less for VMAT compared to CK, HT-F and HT-D (P = 0.036). CI improved for CK (0.69), HT-F (0.66), and HT-D (0.67) compared to VMAT (0.52) (P = 0.013). CK (41.86) had the largest HI compared to VMAT (26.99), HT-F (20.69), and HT-D (21.17) (P < 0.001). GI was significantly less for CK (3.96) compared to VMAT (6.76) (P = 0.001). Likewise, CK (62.4 min, 14059 MU) had the longest treatment time and MU per fraction compared to VMAT (8.5 min, 9764 MU), HT-F (13 min, 10822 MU), and HT-D (13.5 min, 11418 MU) (P < 0.001). CONCLUSION Both CK and HT plans achieved conformal target coverage while respecting cord tolerance. Dose heterogeneity was significantly larger in CK. VMAT required the least treatment time and MU output, but had the least steep GI, CI, and target coverage.
Collapse
Affiliation(s)
- Saif Aljabab
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
| | | | - Eric Vandervoort
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
| | - Jamie Bahm
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
| | - Robert Zohr
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
| | - John Sinclair
- Division of Neurosurgery, University of Ottawa, Ottawa, ON, Canada
| | - Jean-Michel Caudrelier
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.,Ottawa Hospital Research Institute, Ottawa, ON, Canada.,Division of Radiation Oncology, Department of Radiology, University of Ottawa, Ottawa, ON, Canada
| | - Janos Szanto
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
| | - Shawn Malone
- Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.,Ottawa Hospital Research Institute, Ottawa, ON, Canada.,Division of Radiation Oncology, Department of Radiology, University of Ottawa, Ottawa, ON, Canada
| |
Collapse
|
20
|
Paynter D, Weston SJ, Cosgrove VP, Thwaites DI. Characterisation of flattening filter free (FFF) beam properties for initial beam set-up and routine QA, independent of flattened beams. Phys Med Biol 2017; 63:015021. [DOI: 10.1088/1361-6560/aa9a1f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
21
|
Howitz S, Schwedas M, Wiezorek T, Zink K. Experimental and Monte Carlo-based determination of the beam quality specifier for TomoTherapyHD treatment units. Z Med Phys 2017; 28:142-149. [PMID: 29031915 DOI: 10.1016/j.zemedi.2017.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Revised: 08/08/2017] [Accepted: 09/18/2017] [Indexed: 10/18/2022]
Abstract
Reference dosimetry by means of clinical linear accelerators in high-energy photon fields requires the determination of the beam quality specifier TPR20,10, which characterizes the relative particle flux density of the photon beam. The measurement of TPR20,10 has to be performed in homogenous photon beams of size 10×10cm2 with a focus-detector distance of 100cm. These requirements cannot be fulfilled by TomoTherapy treatment units from Accuray. The TomoTherapy unit provides a flattening-filter-free photon fan beam with a maximum field width of 40cm and field lengths of 1.0cm, 2.5cm and 5.0cm at a focus-isocenter distance of 85cm. For the determination of the beam quality specifier from measurements under nonstandard reference conditions Sauer and Palmans proposed experiment-based fit functions. Moreover, Sauer recommends considering the impact of the flattening-filter-free beam on the measured data. To verify these fit functions, in the present study a Monte Carlo based model of the treatment head of a TomoTherapyHD unit was designed and commissioned with existing beam data of our clinical TomoTherapy machine. Depth dose curves and dose profiles were in agreement within 1.5% between experimental and Monte Carlo-based data. Based on the fit functions from Sauer and Palmans the beam quality specifier TPR20,10 was determined from field sizes 5×5cm2, 10×5cm2, 20×5cm2 and 40×5cm2 based on dosimetric measurements and Monte Carlo simulations. The mean value from all experimental values of TPR20,10 resulted in TPR20,10¯=0.635±0.4%. The impact of the non-homogenous field due to the flattening-filter-free beam was negligible for field sizes below 20×5cm2. The beam quality specifier calculated by Monte Carlo simulations was TPR20,10=0.628 and TPR20,10=0.631 for two different calculation methods. The stopping power ratio water-to-air sw,aΔ directly depends on the beam quality specifier. The value determined from all experimental TPR20,10 data was sw,aΔ=1.126±0.1%, which is in excellent agreement with the value directly calculated by Monte Carlo simulations. The agreement is a good indication that the equations proposed by Sauer and Palmans are able to calculate the beam quality specifier under reference conditions from measurements in arbitrary photon field sizes with high accuracy and are applicable for the TomoTherapyHD treatment unit.
Collapse
Affiliation(s)
- Simon Howitz
- University Hospital Jena, Department of Radiation Oncology, Germany; Institute for Medical Physics and Radiation Protection IMPS, University of Applied Science - THM, Giessen, Germany; Philipps-University, Marburg, Germany.
| | - Michael Schwedas
- University Hospital Jena, Department of Radiation Oncology, Germany
| | - Tilo Wiezorek
- University Hospital Jena, Department of Radiation Oncology, Germany
| | - Klemens Zink
- Institute for Medical Physics and Radiation Protection IMPS, University of Applied Science - THM, Giessen, Germany; University Medical Center Giessen-Marburg, Department of Radiation Oncology, Germany; Frankfurt Institute for Advanced Studies (FIAS), Frankfurt, Germany
| |
Collapse
|
22
|
Lechner W, Kuess P, Georg D, Palmans H. Equivalent (uniform) square field sizes of flattening filter free photon beams. ACTA ACUST UNITED AC 2017; 62:7694-7713. [DOI: 10.1088/1361-6560/aa83f5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
23
|
Xu Y, Yan H, Hu Z, Ma P, Men K, Huang P, Ren W, Dai J, Li Y. Influence of tumor location on the intensity-modulated radiation therapy plan of helical tomotherapy. Med Dosim 2017; 42:334-340. [PMID: 28797719 DOI: 10.1016/j.meddos.2017.07.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2016] [Revised: 04/20/2017] [Accepted: 07/03/2017] [Indexed: 11/29/2022]
Abstract
Given the design of the Helical TomoTherapy device, the patient's central axis is routinely aligned with the machine's rotational axis to prevent the patient's body from colliding with the machine walls. However, for treatment of tumors located away from the patient's central axis, this position may not be optimal as the adequate radiation dose may not reach the affected site. Our study aimed to investigate the influence of tumor location on dose quality and delivery efficiency of tomotherapy plans. A phantom and 15 patients were selected for this study. Two plans, A and B, were implemented for each case. In plan A, the patient's central axis was aligned with the machine's rotational axis, whereas in plan B, the center of the planning target volume (PTV) was aligned with the machine's rotational axis. Both plans were optimized with the same planning parameters, and the dose quality of the plans was evaluated using dosimetrics. The delivery efficiency was determined from delivery time and monitor units (MUs). A paired t-test or nonparametric Wilcoxon signed-rank test was performed for statistical comparison. In the phantom study, the median delivery times were 358 and 336 seconds for plans A and B, respectively, and this difference was significant (p = 0.005). In the patient study, the median delivery times were 348 and 317 seconds for plans A and B, respectively, and this difference was also significant (p = 0.001). The dose qualities of both plans for each patient were nearly identical. No significant differences were found in the conformal index, heterogeneity index, and mean dose delivered to normal tissue between the plans. Both phantom and patient studies showed that for normal-sized patients, the delivery time reduced as the distance between the PTV and the patient's central axis increased when the PTV center was aligned with the machine axis. In conclusion, aligning the PTV center with the machine's rotational axis by shifting the patient during tomotherapy reduces the delivery time without compromising the dose quality of intensity-modulated radiation therapy.
Collapse
Affiliation(s)
- Yingjie Xu
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Hui Yan
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Zhihui Hu
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Pan Ma
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Kuo Men
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Peng Huang
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Wenting Ren
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China
| | - Jianrong Dai
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China.
| | - Yexiong Li
- Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuannanli, Chaoyang District, Beijing 100021, China.
| |
Collapse
|
24
|
Radiological properties of 3D printed materials in kilovoltage and megavoltage photon beams. Phys Med 2017; 38:111-118. [DOI: 10.1016/j.ejmp.2017.05.051] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Revised: 05/03/2017] [Accepted: 05/04/2017] [Indexed: 11/22/2022] Open
|
25
|
Comparison of Flattening Filter (FF) and Flattening-Filter-Free (FFF) 6 MV photon beam characteristics for small field dosimetry using EGSnrc Monte Carlo code. Radiat Phys Chem Oxf Engl 1993 2017. [DOI: 10.1016/j.radphyschem.2017.02.029] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
26
|
Hsieh LL, Shieh JI, Wei LJ, Wang YC, Cheng KY, Shih CT. Polymer gel dosimeters for pretreatment radiotherapy verification using the three-dimensional gamma evaluation and pass rate maps. Phys Med 2017; 37:75-81. [PMID: 28535918 DOI: 10.1016/j.ejmp.2017.04.018] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2016] [Revised: 04/17/2017] [Accepted: 04/17/2017] [Indexed: 12/21/2022] Open
Abstract
Polymer gel dosimeters (PGDs) have been widely studied for use in the pretreatment verification of clinical radiation therapy. However, the readability of PGDs in three-dimensional (3D) dosimetry remain unclear. In this study, the pretreatment verifications of clinical radiation therapy were performed using an N-isopropyl-acrylamide (NIPAM) PGD, and the results were used to evaluate the performance of the NIPAM PGD on 3D dose measurement. A gel phantom was used to measure the dose distribution of a clinical case of intensity-modulated radiation therapy. Magnetic resonance imaging scans were performed for dose readouts. The measured dose volumes were compared with the planned dose volume. The relative volume histograms showed that relative volumes with a negative percent dose difference decreased as time elapsed. Furthermore, the histograms revealed few changes after 24h postirradiation. For the 3%/3mm and 2%/2mm criteria, the pass rates of the 12- and 24-h dose volumes were higher than 95%, respectively. This study thus concludes that the pass rate map can be used to evaluate the dose-temporal readability of PGDs and that the NIPAM PGD can be used for clinical pretreatment verifications.
Collapse
Affiliation(s)
- Ling-Ling Hsieh
- Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, No. 666, Buzih Road, Taichung 40601, Taiwan, ROC; Graduate Institute of Biotechnology and Biomedical Engineering, Central Taiwan University of Science and Technology, No. 666, Buzih Road, Taichung 40601, Taiwan, ROC
| | - Jiunn-I Shieh
- Department of M-Commerce and Multimedia Applications, Asia University, No. 500, Lioufeng Road, Taichung 41354, Taiwan, ROC
| | - Li-Ju Wei
- 3D Printing Medical Research Center, China Medical University Hospital, China Medical University, No. 2, Yuh-Der Road, Taichung 40447, Taiwan, ROC
| | - Yi-Chun Wang
- Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, No. 155, Sec. 2, Linong Street, Taipei 11221, Taiwan, ROC; Department of Radiology, China Medical University Hospital, China Medical University, No. 2, Yuh-Der Road, Taichung 40447, Taiwan, ROC
| | - Kai-Yuan Cheng
- Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, No. 666, Buzih Road, Taichung 40601, Taiwan, ROC
| | - Cheng-Ting Shih
- 3D Printing Medical Research Center, China Medical University Hospital, China Medical University, No. 2, Yuh-Der Road, Taichung 40447, Taiwan, ROC.
| |
Collapse
|
27
|
Exploration of Superior Modality: Safety and Efficacy of Hypofractioned Image-Guided Intensity Modulated Radiation Therapy in Patients with Unresectable but Confined Intrahepatic Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2017; 2017:6267981. [PMID: 29098144 PMCID: PMC5643031 DOI: 10.1155/2017/6267981] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 08/10/2017] [Accepted: 09/17/2017] [Indexed: 12/13/2022] Open
Abstract
PURPOSE To evaluate the efficacy and safety of hypofractioned image-guided intensity modulated radiation therapy (IG-IMRT) for unresectable but confined intrahepatic hepatocellular carcinoma in comparison with conventional 3-dimensional conformal radiotherapy (3D-CRT). METHODS Ninety patients with unresectable but confined intrahepatic hepatocellular carcinoma without distant metastasis and tumor thrombosis received external beam radiation therapy. Of these patients, 45 received IG-IMRT and 45 received 3D-CRT. The IG-IMRT design delivered a median total hypofractionated dose of 54 Gy (2.2-5.5 Gy/fx), and 3D-CRT delivered a median total dose of 54 Gy with a conventional fraction (2.0 Gy/fx). The clinical response, overall survival, and side effects were analyzed. RESULTS The IG-IMRT group showed significantly higher 1-year survival (93.3 versus 77.8%) and 2-year survival (73.3 versus 51.1%) and longer median survival (44.7 versus 24.0 months) than the 3D-CRT group. Multivariate analysis indicated that the patients with intrahepatic tumors smaller than 8 cm, prior TACE before RT, and IG-IMRT would have a survival benefit. There were no significant differences in the rates of side effects between the two groups. CONCLUSION Hypofractioned IG-IMRT could improve the therapeutic response and confer a potential survival of patients with unresectable but confined intrahepatic hepatocellular carcinoma compared to 3D-CRT with acceptable toxicity.
Collapse
|
28
|
Ricotti R, Ciardo D, Fattori G, Leonardi MC, Morra A, Dicuonzo S, Rojas DP, Pansini F, Cambria R, Cattani F, Gianoli C, Spinelli C, Riboldi M, Baroni G, Orecchia R, Jereczek-Fossa BA. Intra-fraction respiratory motion and baseline drift during breast Helical Tomotherapy. Radiother Oncol 2017; 122:79-86. [DOI: 10.1016/j.radonc.2016.07.019] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Revised: 07/08/2016] [Accepted: 07/09/2016] [Indexed: 11/30/2022]
|
29
|
Kawashima M, Kawamura H, Onishi M, Takakusagi Y, Okonogi N, Okazaki A, Sekihara T, Ando Y, Nakano T. The Impact of the Grid Size on TomoTherapy for Prostate Cancer. J Med Phys 2017; 42:144-150. [PMID: 28974860 PMCID: PMC5618461 DOI: 10.4103/jmp.jmp_123_16] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Discretization errors due to the digitization of computed tomography images and the calculation grid are a significant issue in radiation therapy. Such errors have been quantitatively reported for a fixed multifield intensity-modulated radiation therapy using traditional linear accelerators. The aim of this study is to quantify the influence of the calculation grid size on the dose distribution in TomoTherapy. This study used ten treatment plans for prostate cancer. The final dose calculation was performed with "fine" (2.73 mm) and "normal" (5.46 mm) grid sizes. The dose distributions were compared from different points of view: the dose-volume histogram (DVH) parameters for planning target volume (PTV) and organ at risk (OAR), the various indices, and dose differences. The DVH parameters were used Dmax, D2%, D2cc, Dmean, D95%, D98%, and Dmin for PTV and Dmax, D2%, and D2cc for OARs. The various indices used were homogeneity index and equivalent uniform dose for plan evaluation. Almost all of DVH parameters for the "fine" calculations tended to be higher than those for the "normal" calculations. The largest difference of DVH parameters for PTV was Dmax and that for OARs was rectal D2cc. The mean difference of Dmax was 3.5%, and the rectal D2cc was increased up to 6% at the maximum and 2.9% on average. The mean difference of D95% for PTV was the smallest among the differences of the other DVH parameters. For each index, whether there was a significant difference between the two grid sizes was determined through a paired t-test. There were significant differences for most of the indices. The dose difference between the "fine" and "normal" calculations was evaluated. Some points around high-dose regions had differences exceeding 5% of the prescription dose. The influence of the calculation grid size in TomoTherapy is smaller than traditional linear accelerators. However, there was a significant difference. We recommend calculating the final dose using the "fine" grid size.
Collapse
Affiliation(s)
| | - Hidemasa Kawamura
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
| | - Masahiro Onishi
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
| | | | - Noriyuki Okonogi
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.,Hospital, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan
| | | | | | | | - Takashi Nakano
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
| |
Collapse
|
30
|
Yuan J, Zheng Y, Wessels B, Lo SS, Ellis R, Machtay M, Yao M. Experimental Validation of Monte Carlo Simulations Based on a Virtual Source Model for TomoTherapy in a RANDO Phantom. Technol Cancer Res Treat 2016; 15:796-804. [DOI: 10.1177/1533034615605007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2015] [Revised: 07/29/2015] [Accepted: 08/17/2015] [Indexed: 11/17/2022] Open
Abstract
A virtual source model for Monte Carlo simulations of helical TomoTherapy has been developed previously by the authors. The purpose of this work is to perform experiments in an anthropomorphic (RANDO) phantom with the same order of complexity as in clinical treatments to validate the virtual source model to be used for quality assurance secondary check on TomoTherapy patient planning dose. Helical TomoTherapy involves complex delivery pattern with irregular beam apertures and couch movement during irradiation. Monte Carlo simulation, as the most accurate dose algorithm, is desirable in radiation dosimetry. Current Monte Carlo simulations for helical TomoTherapy adopt the full Monte Carlo model, which includes detailed modeling of individual machine component, and thus, large phase space files are required at different scoring planes. As an alternative approach, we developed a virtual source model without using the large phase space files for the patient dose calculations previously. In this work, we apply the simulation system to recompute the patient doses, which were generated by the treatment planning system in an anthropomorphic phantom to mimic the real patient treatments. We performed thermoluminescence dosimeter point dose and film measurements to compare with Monte Carlo results. Thermoluminescence dosimeter measurements show that the relative difference in both Monte Carlo and treatment planning system is within 3%, with the largest difference less than 5% for both the test plans. The film measurements demonstrated 85.7% and 98.4% passing rate using the 3 mm/3% acceptance criterion for the head and neck and lung cases, respectively. Over 95% passing rate is achieved if 4 mm/4% criterion is applied. For the dose–volume histograms, very good agreement is obtained between the Monte Carlo and treatment planning system method for both cases. The experimental results demonstrate that the virtual source model Monte Carlo system can be a viable option for the accurate dose calculation of helical TomoTherapy.
Collapse
Affiliation(s)
- Jiankui Yuan
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| | - Yiran Zheng
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| | - Barry Wessels
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| | - Simon S. Lo
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| | - Rodney Ellis
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| | | | - Min Yao
- University Hospitals, Case Medical Center, Cleveland, OH, USA
| |
Collapse
|
31
|
Pardo E, Novais JC, Molina López MY, Ruiz Maqueda S. On flattening filter-free portal dosimetry. J Appl Clin Med Phys 2016; 17:132-145. [PMID: 27455487 PMCID: PMC5690039 DOI: 10.1120/jacmp.v17i4.6147] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Revised: 02/29/2016] [Accepted: 02/25/2016] [Indexed: 11/23/2022] Open
Abstract
Varian introduced (in 2010) the option of removing the flattening filter (FF) in their C‐Arm linacs for intensity‐modulated treatments. This mode, called flattening filter‐free (FFF), offers the advantage of a greater dose rate. Varian's “Portal Dosimetry” is an electronic portal imager device (EPID)‐based tool for IMRT verification. This tool lacks the capability of verifying flattening filter‐free (FFF) modes due to saturation and lack of an image prediction algorithm. (Note: the latest versions of this software and EPID correct these issues.) The objective of the present study is to research the feasibility of said verifications (with the older versions of the software and EPID). By placing the EPID at a greater distance, the images can be acquired without saturation, yielding a linearity similar to the flattened mode. For the image prediction, a method was optimized based on the clinically used algorithm (analytical anisotropic algorithm (AAA)) over a homogeneous phantom. The depth inside the phantom and its electronic density were tailored. An application was developed to allow the conversion of a dose plane (in DICOM format) to Varian's custom format for Portal Dosimetry. The proposed method was used for the verification of test and clinical fields for the three qualities used in our institution for IMRT: 6X, 6FFF and 10FFF. The method developed yielded a positive verification (more than 95% of the points pass a 2%/2 mm gamma) for both the clinical and test fields. This method was also capable of “predicting” static and wedged fields. A workflow for the verification of FFF fields was developed. This method relies on the clinical algorithm used for dose calculation and is able to verify the FFF modes, as well as being useful for machine quality assurance. The procedure described does not require new hardware. This method could be used as a verification of Varian's Portal Dose Image Prediction. PACS number(s): 87.53.Kn, 87.55.T‐, 87.56.bd, 87.59.‐e
Collapse
|
32
|
Tyler MK, Liu PZY, Lee C, McKenzie DR, Suchowerska N. Small field detector correction factors: effects of the flattening filter for Elekta and Varian linear accelerators. J Appl Clin Med Phys 2016; 17:223-235. [PMID: 27167280 PMCID: PMC5690940 DOI: 10.1120/jacmp.v17i3.6059] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 01/12/2016] [Accepted: 01/11/2016] [Indexed: 11/24/2022] Open
Abstract
Flattening filter‐free (FFF) beams are becoming the preferred beam type for stereotactic radiosurgery (SRS) and stereotactic ablative radiation therapy (SABR), as they enable an increase in dose rate and a decrease in treatment time. This work assesses the effects of the flattening filter on small field output factors for 6 MV beams generated by both Elekta and Varian linear accelerators, and determines differences between detector response in flattened (FF) and FFF beams. Relative output factors were measured with a range of detectors (diodes, ionization chambers, radiochromic film, and microDiamond) and referenced to the relative output factors measured with an air core fiber optic dosimeter (FOD), a scintillation dosimeter developed at Chris O'Brien Lifehouse, Sydney. Small field correction factors were generated for both FF and FFF beams. Diode measured detector response was compared with a recently published mathematical relation to predict diode response corrections in small fields. The effect of flattening filter removal on detector response was quantified using a ratio of relative detector responses in FFF and FF fields for the same field size. The removal of the flattening filter was found to have a small but measurable effect on ionization chamber response with maximum deviations of less than ±0.9% across all field sizes measured. Solid‐state detectors showed an increased dependence on the flattening filter of up to ±1.6%. Measured diode response was within ±1.1% of the published mathematical relation for all fields up to 30 mm, independent of linac type and presence or absence of a flattening filter. For 6 MV beams, detector correction factors between FFF and FF beams are interchangeable for a linac between FF and FFF modes, providing that an additional uncertainty of up to ±1.6% is accepted. PACS number(s): 87.55.km, 87.56.bd, 87.56.Da
Collapse
|
33
|
Kamkaew A, Chen F, Zhan Y, Majewski RL, Cai W. Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. ACS NANO 2016; 10:3918-35. [PMID: 27043181 PMCID: PMC4846476 DOI: 10.1021/acsnano.6b01401] [Citation(s) in RCA: 226] [Impact Index Per Article: 28.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
Achieving effective treatment of deep-seated tumors is a major challenge for traditional photodynamic therapy (PDT) due to difficulties in delivering light into the subsurface. Thanks to their great tissue penetration, X-rays hold the potential to become an ideal excitation source for activating photosensitizers (PS) that accumulate in deep tumor tissue. Recently, a wide variety of nanoparticles have been developed for this purpose. The nanoparticles are designed as carriers for loading various kinds of PSs and can facilitate the activation process by transferring energy harvested from X-ray irradiation to the loaded PS. In this review, we focus on recent developments of nanoscintillators with high energy transfer efficiency, their rational designs, as well as potential applications in next-generation PDT. Treatment of deep-seated tumors by using radioisotopes as an internal light source will also be discussed.
Collapse
Affiliation(s)
- Anyanee Kamkaew
- Department of Radiology, University of Wisconsin - Madison, Wisconsin 53705, United States
| | - Feng Chen
- Department of Radiology, University of Wisconsin - Madison, Wisconsin 53705, United States
- Corresponding Author: Feng Chen: ; Weibo Cai:
| | - Yonghua Zhan
- Department of Radiology, University of Wisconsin - Madison, Wisconsin 53705, United States
- Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education & School of Life Science and Technology, Xidian University, Xi’an, Shaanxi 710071, China
| | - Rebecca L. Majewski
- Department of Biomedical Engineering, University of Wisconsin - Madison, Wisconsin 53705, United States
| | - Weibo Cai
- Department of Radiology, University of Wisconsin - Madison, Wisconsin 53705, United States
- Department of Medical Physics, University of Wisconsin - Madison, Wisconsin 53705, United States
- University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53705, United States
- Corresponding Author: Feng Chen: ; Weibo Cai:
| |
Collapse
|
34
|
Yang J, Ma L, Wang XS, Xu WX, Cong XH, Xu SP, Ju ZJ, Du L, Cai BN, Yang J. Dosimetric evaluation of 4 different treatment modalities for curative-intent stereotactic body radiation therapy for isolated thoracic spinal metastases. Med Dosim 2016; 41:105-12. [PMID: 26831753 DOI: 10.1016/j.meddos.2015.10.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Revised: 09/28/2015] [Accepted: 10/14/2015] [Indexed: 12/25/2022]
Abstract
To investigate the dosimetric characteristics of 4 SBRT-capable dose delivery systems, CyberKnife (CK), Helical TomoTherapy (HT), Volumetric Modulated Arc Therapy (VMAT) by Varian RapidArc (RA), and segmental step-and-shoot intensity-modulated radiation therapy (IMRT) by Elekta, on isolated thoracic spinal lesions. CK, HT, RA, and IMRT planning were performed simultaneously for 10 randomly selected patients with 6 body types and 6 body + pedicle types with isolated thoracic lesions. The prescription was set with curative intent and dose of either 33Gy in 3 fractions (3F) or 40Gy in 5F to cover at least 90% of the planning target volume (PTV), correspondingly. Different dosimetric indices, beam-on time, and monitor units (MUs) were evaluated to compare the advantages/disadvantages of each delivery modality. In ensuring the dose-volume constraints for cord and esophagus of the premise, CK, HT, and RA all achieved a sharp conformity index (CI) and a small penumbra volume compared to IMRT. RA achieved a CI comparable to those from CK, HT, and IMRT. CK had a heterogeneous dose distribution in the target as its radiosurgical nature with less dose uniformity inside the target. CK had the longest beam-on time and the largest MUs, followed by HT and RA. IMRT presented the shortest beam-on time and the least MUs delivery. For the body-type lesions, CK, HT, and RA satisfied the target coverage criterion in 6 cases, but the criterion was satisfied in only 3 (50%) cases with the IMRT technique. For the body + pedicle-type lesions, HT satisfied the criterion of the target coverage of ≥90% in 4 of the 6 cases, and reached a target coverage of 89.0% in another case. However, the criterion of the target coverage of ≥90% was reached in 2 cases by CK and RA, and only in 1 case by IMRT. For curative-intent SBRT of isolated thoracic spinal lesions, RA is the first choice for the body-type lesions owing to its delivery efficiency (time); the second choice is CK or HT; HT is the preferential choice for the body + pedicle-type lesions. This study suggests further clinical investigations with longer follow-up for these studied cases.
Collapse
Affiliation(s)
- Jun Yang
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China; Department of Oncology, First Affiliated Hospital of Xinxiang Medical University, 88 Jiankang Road, Weihui, Henan, 453100, China
| | - Lin Ma
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China; Department of Radiation Oncology, Hainan Branch of Chinese PLA General Hospital, Haitang Bay, Sanya, 572000, China
| | - Xiao-Shen Wang
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Wei Xu Xu
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Xiao-Hu Cong
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Shou-Ping Xu
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Zhong-Jian Ju
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Lei Du
- Department of Radiation Oncology, Hainan Branch of Chinese PLA General Hospital, Haitang Bay, Sanya, 572000, China
| | - Bo-Ning Cai
- Department of Radiation Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China
| | - Jack Yang
- Department of Radiation Oncology, Monmouth Medical Center, 300 2nd Avenue, Long Branch, NJ 07740, USA
| |
Collapse
|
35
|
Blanco Kiely JP, White BM, Low DA, Qi SX. Geometric validation of MV topograms for patient localization on TomoTherapy. Phys Med Biol 2016; 61:728-39. [PMID: 26717197 DOI: 10.1088/0031-9155/61/2/728] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Our goal was to geometrically validate the use of mega-voltage orthogonal scout images (MV topograms) as a fast and low-dose alternative to mega-voltage computed tomography (MVCT) for daily patient localization on the TomoTherapy system. To achieve this, anthropomorphic head and pelvis phantoms were imaged on a 16-slice kilo-voltage computed tomography (kVCT) scanner to synthesize kilo-voltage digitally reconstructed topograms (kV-DRT) in the Tomotherapy detector geometry. MV topograms were generated for couch speeds of 1-4 cm s(-1) in 1 cm s(-1) increments with static gantry angles in the anterior-posterior and left-lateral directions. Phantoms were rigidly translated in the anterior-posterior (AP), superior-inferior (SI), and lateral (LAT) directions to simulate potential setup errors. Image quality improvement was demonstrated by estimating the noise level in the unenhanced and enhanced MV topograms using a principle component analysis-based noise level estimation algorithm. Average noise levels for the head phantom were reduced by 2.53 HU (AP) and 0.18 HU (LAT). The pelvis phantom exhibited average noise level reduction of 1.98 HU (AP) and 0.48 HU (LAT). Mattes Mutual Information rigid registration was used to register enhanced MV topograms with corresponding kV-DRT. Registration results were compared to the known rigid displacements, which assessed the MV topogram localization's sensitivity to daily positioning errors. Reduced noise levels in the MV topograms enhanced the registration results so that registration errors were <1 mm. The unenhanced head MV topograms had discrepancies < 2.1 mm and the pelvis topograms had discrepancies < 2.7 mm. Result were found to be consistent regardless of couch speed. In total, 64.7% of the head phantom MV topograms and 60.0% of the pelvis phantom MV topograms exactly measured the phantom offsets. These consistencies demonstrated the potential for daily patient positioning using MV topogram pairs in the context bony-anatomy based procedures such as total marrow irradiation, total body irradiation, and cranial spinal irradiation.
Collapse
Affiliation(s)
- Janid P Blanco Kiely
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
| | | | | | | |
Collapse
|
36
|
Mege JP, Wenzhao S, Veres A, Auzac G, Diallo I, Lefkopoulos D. Evaluation of MVCT imaging dose levels during helical IGRT: comparison between ion chamber, TLD, and EBT3 films. J Appl Clin Med Phys 2016; 17:143-157. [PMID: 26894346 PMCID: PMC5690206 DOI: 10.1120/jacmp.v17i1.5774] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2015] [Revised: 08/19/2015] [Accepted: 07/02/2015] [Indexed: 11/23/2022] Open
Abstract
The purpose of this investigation was to evaluate the dose on megavoltage CT (MVCT) images required for tomotherapy. As imaging possibilities are often used before each treatment and usually used several times before the session, we tried to evaluate the dose delivered during the procedure. For each scanning mode (fine, normal, and coarse), we first established the relative variation of these doses according to different technical parameters (explored length, patient setup). These dose variations measured with the TomoPhant, also known as Cheese phantom, showed the expected variations (due to the variation of scattered radiation) of 15% according to the explored length and ± 5% according to the phantom setup (due to the variation of the point of measurement in the bore). In order to estimate patient doses, an anthropomorphic phantom was used for thermoluminescent and film dosimetry. The degree of agreement between the two methods was very satisfactory (the differences correspond to 5 mGy per imaging session) for the three sites studied (head & neck, thorax, and abdomen). These measurements allowed us to estimate the delivered dose of between 1 cGy and 4 cGy according to the site and imaging mode. Finally, we attempted to investigate a way to calculate this delivered dose in our patients from the study conducted on a cylindrical phantom and by taking into account data from the initial kV-CT scan. The results we obtained were close to our measurements, with discrepancies below 5 mGy per MVCT.
Collapse
|
37
|
Park K, Lee Y, Cha J, You SH, Kim S, Lee JY. Influence of different boost techniques on radiation dose to the left anterior descending coronary artery. Radiat Oncol J 2015; 33:242-9. [PMID: 26484308 PMCID: PMC4607578 DOI: 10.3857/roj.2015.33.3.242] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 09/02/2015] [Accepted: 09/07/2015] [Indexed: 12/25/2022] Open
Abstract
Purpose The purpose of this study is to compare the dosimetry of electron beam (EB) plans and three-dimensional helical tomotherapy (3DHT) plans for the patients with left-sided breast cancer, who underwent breast conserving surgery. Materials and Methods We selected total of 15 patients based on the location of tumor, as following subsite: subareolar, upper outer, upper inner, lower lateral, and lower medial quadrants. The clinical target volume (CTV) was defined as the area of architectural distortion surrounded by surgical clip plus 1 cm margin. The conformity index (CI), homogeneity index (HI), quality of coverage (QC) and dose-volume parameters for the CTV, and organ at risk (OAR) were calculated. The following treatment techniques were assessed: single conformal EB plans; 3DHT plans with directional block of left anterior descending artery (LAD); and 3DHT plans with complete block of LAD. Results 3DHT plans, regardless of type of LAD block, showed significantly better CI, HI, and QC for the CTVs, compared with the EB plans. However, 3DHT plans showed increase in the V1Gy at skin, left lung, and left breast. In terms of LAD, 3DHT plans with complete block of LAD showed extremely low dose, while dose increase in other OARs were observed, when compared with other plans. EB plans showed the worst conformity at upper outer quadrants of tumor bed site. Conclusion 3DHT plans offer more favorable dose distributions to LAD, as well as improved target coverage in comparison with EB plans.
Collapse
Affiliation(s)
- Kawngwoo Park
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Yongha Lee
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Jihye Cha
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Sei Hwan You
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Sunghyun Kim
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Jong Young Lee
- Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea
| |
Collapse
|
38
|
Alnaghy SJ, Deshpande S, Cutajar DL, Berk K, Metcalfe P, Rosenfeld AB. In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors. J Appl Clin Med Phys 2015; 16:5113. [PMID: 26103477 PMCID: PMC5690127 DOI: 10.1120/jacmp.v16i3.5113] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2014] [Revised: 01/06/2015] [Accepted: 01/06/2015] [Indexed: 11/23/2022] Open
Abstract
Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom-based study was completed, aimed at developing a system for measurement of anterior rectal wall doses during hypofractionated prostate stereotactic body radiotherapy (SBRT) utilizing tomotherapy delivery. An array of four dual MOSkinTM dosimeters, spaced 1 cm apart, was placed on a replica Rectafix® immobilization spacer device. This Perspex probe is a more rigid alternative to rectal balloons, to improve geometric reproducibility. The doses at each point were measured in real time and compared to doses calculated by the treatment planning system (TPS). Additionally, distance-to-agreement (DTA) measurements were acquired to assist in the comparison of measured and predicted doses. All dual MOSkin detectors measured dose to within ± 5% of the TPS at the anterior rectal wall. Whilst several points were outside of experimental error, the largest deviation from the TPS predicted dose represented a DTA of only 1.3 mm, within the acceptable DTA tolerance of 3 mm. Larger deviations of up to -11.9% were observed for the posterior and side walls; however, if acceptable DTA measurements are accounted for, then an agreement of 75% was observed. Although larger differences were observed at the other rectal wall locations, the overall effect of dose at these points was not as significant, given the lower doses. Despite the very high-dose gradient region, real-time measurements of the anterior rectal wall doses were within acceptable limits of TPS-predicted doses. The differences between measured and planned data were due to difficulties in precisely locating each detector on the TPS dose grid, which presented large variations in dose between CT voxels in regions of steep dose gradients. The dual MOSkin system would, therefore, be a useful device for detecting errors in real time, such as patient shifts or incorrect setup, during tomotherapy of the prostate.
Collapse
Affiliation(s)
- Sarah J Alnaghy
- Centre for Medical Radiation Physics, University of Wollongong.
| | | | | | | | | | | |
Collapse
|
39
|
Xiao Y, Kry SF, Popple R, Yorke E, Papanikolaou N, Stathakis S, Xia P, Huq S, Bayouth J, Galvin J, Yin FF. Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys 2015; 16:5219. [PMID: 26103482 PMCID: PMC5690108 DOI: 10.1120/jacmp.v16i3.5219] [Citation(s) in RCA: 116] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2014] [Revised: 02/06/2015] [Accepted: 01/23/2015] [Indexed: 11/23/2022] Open
Abstract
This report describes the current state of flattening filter‐free (FFF) radiotherapy beams implemented on conventional linear accelerators, and is aimed primarily at practicing medical physicists. The Therapy Emerging Technology Assessment Work Group of the American Association of Physicists in Medicine (AAPM) formed a writing group to assess FFF technology. The published literature on FFF technology was reviewed, along with technical specifications provided by vendors. Based on this information, supplemented by the clinical experience of the group members, consensus guidelines and recommendations for implementation of FFF technology were developed. Areas in need of further investigation were identified. Removing the flattening filter increases beam intensity, especially near the central axis. Increased intensity reduces treatment time, especially for high‐dose stereotactic radiotherapy/radiosurgery (SRT/SRS). Furthermore, removing the flattening filter reduces out‐of‐field dose and improves beam modeling accuracy. FFF beams are advantageous for small field (e.g., SRS) treatments and are appropriate for intensity‐modulated radiotherapy (IMRT). For conventional 3D radiotherapy of large targets, FFF beams may be disadvantageous compared to flattened beams because of the heterogeneity of FFF beam across the target (unless modulation is employed). For any application, the nonflat beam characteristics and substantially higher dose rates require consideration during the commissioning and quality assurance processes relative to flattened beams, and the appropriate clinical use of the technology needs to be identified. Consideration also needs to be given to these unique characteristics when undertaking facility planning. Several areas still warrant further research and development. Recommendations pertinent to FFF technology, including acceptance testing, commissioning, quality assurance, radiation safety, and facility planning, are presented. Examples of clinical applications are provided. Several of the areas in which future research and development are needed are also indicated. PACS number: 87.53.‐j, 87.53.Bn, 87.53.Ly, 87.55.‐x, 87.55.N‐, 87.56.bc
Collapse
Affiliation(s)
- Ying Xiao
- Thomas Jefferson University Hospital.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Wilhelm-Buchstab T, Buchstab BM, Leitzen C, Garbe S, Müdder T, Oberste-Beulmann S, Sprinkart AM, Simon B, Nelles M, Block W, Schoroth F, Schild HH, Schüller H. Extraretinal induced visual sensations during IMRT of the brain. PLoS One 2015; 10:e0123440. [PMID: 25875609 PMCID: PMC4398354 DOI: 10.1371/journal.pone.0123440] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2015] [Accepted: 03/03/2015] [Indexed: 11/19/2022] Open
Abstract
Background We observed visual sensations (VSs) in patients undergoing intensity modulated radiotherapy (IMRT) of the brain without the beam passing through ocular structures. We analyzed this phenomenon especially with regards to reproducibility, and origin. Methods and Findings Analyzed were ten consecutive patients (aged 41-71 years) with glioblastoma multiforme who received pulsed IMRT (total dose 60Gy) with helical tomotherapy (TT). A megavolt—CT (MVCT) was performed daily before treatment. VSs were reported and recorded using a triggered event recorder. The frequency of VSs was calculated and VSs were correlated with beam direction and couch position. Subjective patient perception was plotted on an 8x8 visual field (VF) matrix. Distance to the orbital roof (OR) from the first beam causing a VS was calculated from the Dicom radiation therapy data and MVCT data. During 175 treatment sessions (average 17.5 per patient) 5959 VSs were recorded and analyzed. VSs occurred only during the treatment session not during the MVCTs. Plotting events over time revealed patient-specific patterns. The average cranio-caudad extension of VS-inducing area was 63.4mm (range 43.24-92.1mm). The maximum distance between the first VS and the OR was 56.1mm so that direct interaction with the retina is unlikely. Data on subjective visual perception showed that VSs occurred mainly in the upper right and left quadrants of the VF. Within the visual pathways the highest probability for origin of VSs was seen in the optic chiasm and the optic tract (22%). Conclusions There is clear evidence that interaction of photon irradiation with neuronal structures distant from the eye can lead to VSs.
Collapse
Affiliation(s)
- Timo Wilhelm-Buchstab
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
- * E-mail:
| | - Barbara Myrthe Buchstab
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Christina Leitzen
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Stephan Garbe
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Thomas Müdder
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Susanne Oberste-Beulmann
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Alois Martin Sprinkart
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Birgit Simon
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Michael Nelles
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Wolfgang Block
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Felix Schoroth
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Hans Heinz Schild
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| | - Heinrich Schüller
- University of Bonn, Department of Radiology, Radiooncology, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland, Germany
| |
Collapse
|
41
|
Follow-up of patients with mycosis fungoides after interferon α2b treatment failure. Postepy Dermatol Alergol 2015; 32:67-72. [PMID: 26015774 PMCID: PMC4436229 DOI: 10.5114/pdia.2014.40941] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2013] [Revised: 09/20/2013] [Accepted: 10/28/2013] [Indexed: 01/22/2023] Open
Abstract
INTRODUCTION Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS We present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy. RESULTS Overall response rate for second line therapy was 60%. CONCLUSIONS Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion.
Collapse
|
42
|
Caprile P, Hartmann GH, Doerner E. Development and application of a dose verification tool using a small field model for TomoTherapy. Z Med Phys 2015; 25:48-57. [PMID: 25081067 DOI: 10.1016/j.zemedi.2014.07.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2013] [Revised: 07/02/2014] [Accepted: 07/03/2014] [Indexed: 11/26/2022]
|
43
|
Kang DG, Park SI, Kim SH, Chung MJ, Lee KM, Lee JH. Evaluation of the Flash effect in breast irradiation using TomoDirect: an investigational study. JOURNAL OF RADIATION RESEARCH 2015; 56:397-404. [PMID: 25672612 PMCID: PMC4380062 DOI: 10.1093/jrr/rru118] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/21/2014] [Revised: 09/25/2014] [Accepted: 11/05/2014] [Indexed: 06/04/2023]
Abstract
Flash is a specified function in TomoDirect that enables beam expansion by opening additional leaves to the target. This study assessed the theoretical dose distribution resulting from Flash in breast irradiation using TomoDirect. A cylindrical phantom that enabled dose distribution of the breast was used for verifying the effect of planning target volume (PTV) contouring and Flash. A total of 18 Gy in 10 fractions were prescribed to the PTV. Five PTVs were then created by Contracting this contour by 0, 1, 2, 3, 4 and 5 mm, giving PTV-x. Flash ±x is defined by opening x (number) of the leaves. The Flash effect in the air was compared with each set-up error of 5, 10 and 15 mm, respectively. The minimum PTV dose from PTV-1 to PTV-3 increased from 13.88 Gy to 15.86 Gy. In contrast, Dmin in PTV-4 and PTV-5 was 17.80 Gy in 98.88% of the prescription dose. Without Flash, when 5-, 10- and 15-mm set-up errors applied in the PTV, relative doses of 87.88, 23.73 and 7.94% were observed, respectively. However, in Flash 3, which was equal to the usual air margin of 1.875 cm, a relative dose of 104.24% ± 0.30% was observed, irrespective of set-up errors (5 mm to 15 mm). Flash opening is useful for countervailing set-up errors in breast cancer patients who receive breast irradiation with TomoDirect.
Collapse
Affiliation(s)
- Dae Gyu Kang
- Department of Radiation Oncology, St Vincent's Hospital, the Catholic University of Korea, 93, Ji-dong, Paldal-gu, Suwon, Gyeonggi-do, Korea Department of Biomedical Engineering, Electronic Engineering, Jeju National University of Korea, Jeju-si, Jeju Special Self-Governing Province, Korea
| | - Sung Ill Park
- Department of Medical Physics, Kyong-gi University of Korea, Yeongtong-gu, Suwon, Gyeonggi-do, Korea
| | - Sung Hwan Kim
- Department of Radiation Oncology, St Vincent's Hospital, the Catholic University of Korea, 93, Ji-dong, Paldal-gu, Suwon, Gyeonggi-do, Korea
| | - Mi Joo Chung
- Department of Radiation Oncology, St Vincent's Hospital, the Catholic University of Korea, 93, Ji-dong, Paldal-gu, Suwon, Gyeonggi-do, Korea
| | - Kwang-Man Lee
- Department of Biomedical Engineering, Electronic Engineering, Jeju National University of Korea, Jeju-si, Jeju Special Self-Governing Province, Korea
| | - Jong Hoon Lee
- Department of Radiation Oncology, St Vincent's Hospital, the Catholic University of Korea, 93, Ji-dong, Paldal-gu, Suwon, Gyeonggi-do, Korea
| |
Collapse
|
44
|
Moutrie V, Kairn T, Rosenfeld A, Charles PH. Use of a megavoltage electronic portal imaging device to identify prosthetic materials. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE 2015; 38:93-100. [DOI: 10.1007/s13246-015-0327-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2014] [Accepted: 01/05/2015] [Indexed: 11/30/2022]
|
45
|
Peng JL, Ashenafi MS, McDonald DG, Vanek KN. Assessment of a three-dimensional (3D) water scanning system for beam commissioning and measurements on a helical tomotherapy unit. J Appl Clin Med Phys 2015; 16:4980. [PMID: 25679156 PMCID: PMC5689986 DOI: 10.1120/jacmp.v16i1.4980] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2014] [Revised: 08/22/2014] [Accepted: 08/21/2014] [Indexed: 11/23/2022] Open
Abstract
Beam scanning data collected on the tomotherapy linear accelerator using the TomoScanner water scanning system is primarily used to verify the golden beam profiles included in all Helical TomoTherapy treatment planning systems (TOMO TPSs). The user is not allowed to modify the beam profiles/parameters for beam modeling within the TOMO TPSs. The authors report the first feasibility study using the Blue Phantom Helix (BPH) as an alternative to the TomoScanner (TS) system. This work establishes a benchmark dataset using BPH for target commissioning and quality assurance (QA), and quantifies systematic uncertainties between TS and BPH. Reproducibility of scanning with BPH was tested by three experienced physicists taking five sets of measurements over a six‐month period. BPH provides several enhancements over TS, including a 3D scanning arm, which is able to acquire necessary beam‐data with one tank setup, a universal chamber mount, and the OmniPro software, which allows online data collection and analysis. Discrepancies between BPH and TS were estimated by acquiring datasets with each tank. In addition, data measured with BPH and TS was compared to the golden TOMO TPS beam data. The total systematic uncertainty, defined as the combination of scanning system and beam modeling uncertainties, was determined through numerical analysis and tabulated. OmniPro was used for all analysis to eliminate uncertainty due to different data processing algorithms. The setup reproducibility of BPH remained within 0.5 mm/0.5%. Comparing BPH, TS, and Golden TPS for PDDs beyond maximum depth, the total systematic uncertainties were within 1.4 mm/2.1%. Between BPH and TPS golden data, maximum differences in the field width and penumbra of in‐plane profiles were within 0.8 and 1.1 mm, respectively. Furthermore, in cross‐plane profiles, the field width differences increased at depth greater than 10 cm up to 2.5 mm, and maximum penumbra uncertainties were 5.6 mm and 4.6 mm from TS scanning system and TPS modeling, respectively. Use of BPH reduced measurement time by 1–2 hrs per session. The BPH has been assessed as an efficient, reproducible, and accurate scanning system capable of providing a reliable benchmark beam data. With this data, a physicist can utilize the BPH in a clinical setting with an understanding of the scan discrepancy that may be encountered while validating the TPS or during routine machine QA. Without the flexibility of modifying the TPS and without a golden beam dataset from the vendor or a TPS model generated from data collected with the BPH, this represents the best solution for current clinical use of the BPH. PACS number: 87.56.Fc
Collapse
|
46
|
Yuan J, Rong Y, Chen Q. A virtual source model for Monte Carlo simulation of helical tomotherapy. J Appl Clin Med Phys 2015; 16:4992. [PMID: 25679157 PMCID: PMC5689983 DOI: 10.1120/jacmp.v16i1.4992] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Revised: 08/29/2014] [Accepted: 08/25/2014] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to present a Monte Carlo (MC) simulation method based on a virtual source, jaw, and MLC model to calculate dose in patient for helical tomotherapy without the need of calculating phase‐space files (PSFs). Current studies on the tomotherapy MC simulation adopt a full MC model, which includes extensive modeling of radiation source, primary and secondary jaws, and multileaf collimator (MLC). In the full MC model, PSFs need to be created at different scoring planes to facilitate the patient dose calculations. In the present work, the virtual source model (VSM) we established was based on the gold standard beam data of a tomotherapy unit, which can be exported from the treatment planning station (TPS). The TPS‐generated sinograms were extracted from the archived patient XML (eXtensible Markup Language) files. The fluence map for the MC sampling was created by incorporating the percentage leaf open time (LOT) with leaf filter, jaw penumbra, and leaf latency contained from sinogram files. The VSM was validated for various geometry setups and clinical situations involving heterogeneous media and delivery quality assurance (DQA) cases. An agreement of <1% was obtained between the measured and simulated results for percent depth doses (PDDs) and open beam profiles for all three jaw settings in the VSM commissioning. The accuracy of the VSM leaf filter model was verified in comparing the measured and simulated results for a Picket Fence pattern. An agreement of <2% was achieved between the presented VSM and a published full MC model for heterogeneous phantoms. For complex clinical head and neck (HN) cases, the VSM‐based MC simulation of DQA plans agreed with the film measurement with 98% of planar dose pixels passing on the 2%/2 mm gamma criteria. For patient treatment plans, results showed comparable dose‐volume histograms (DVHs) for planning target volumes (PTVs) and organs at risk (OARs). Deviations observed in this study were consistent with literature. The VSM‐based MC simulation approach can be feasibly built from the gold standard beam model of a tomotherapy unit. The accuracy of the VSM was validated against measurements in homogeneous media, as well as published full MC model in heterogeneous media. PACS numbers: 87.53.‐j, 87.55.K‐
Collapse
|
47
|
Takahashi Y, Vagge S, Agostinelli S, Han E, Matulewicz L, Schubert K, Chityala R, Ratanatharathorn V, Tournel K, Penagaricano JA, Florian S, Mahe MA, Verneris MR, Weisdorf DJ, Corvo R, Dusenbery KE, Storme G, Hui SK. Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation. Int J Radiat Oncol Biol Phys 2014; 91:30-8. [PMID: 25442340 DOI: 10.1016/j.ijrobp.2014.09.014] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2014] [Revised: 08/08/2014] [Accepted: 09/10/2014] [Indexed: 10/24/2022]
Abstract
PURPOSE To develop, characterize, and implement a fast patient localization method for total marrow irradiation. METHODS AND MATERIALS Topographic images were acquired using megavoltage computed tomography (MVCT) detector data by delivering static orthogonal beams while the couch traversed through the gantry. Geometric and detector response corrections were performed to generate a megavoltage topogram (MVtopo). We also generated kilovoltage topograms (kVtopo) from the projection data of 3-dimensional CT images to reproduce the same geometry as helical tomotherapy. The MVtopo imaging dose and the optimal image acquisition parameters were investigated. A multi-institutional phantom study was performed to verify the image registration uncertainty. Forty-five MVtopo images were acquired and analyzed with in-house image registration software. RESULTS The smallest jaw size (front and backup jaws of 0) provided the best image contrast and longitudinal resolution. Couch velocity did not affect the image quality or geometric accuracy. The MVtopo dose was less than the MVCT dose. The image registration uncertainty from the multi-institutional study was within 2.8 mm. In patient localization, the differences in calculated couch shift between the registration with MVtopo-kVtopo and MVCT-kVCT images in lateral, cranial-caudal, and vertical directions were 2.2 ± 1.7 mm, 2.6 ± 1.4 mm, and 2.7 ± 1.1 mm, respectively. The imaging time in MVtopo acquisition at the couch speed of 3 cm/s was <1 minute, compared with ≥15 minutes in MVCT for all patients. CONCLUSION Whole-body MVtopo imaging could be an effective alternative to time-consuming MVCT for total marrow irradiation patient localization.
Collapse
Affiliation(s)
- Yutaka Takahashi
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
| | - Stefano Vagge
- Department of Radiation Oncology, Instituto Nazionale per la Ricerca sul Cancro-National Institute for Cancer Research and University of Genoa, Genoa, Italy
| | - Stefano Agostinelli
- Department of Radiation Oncology, Instituto Nazionale per la Ricerca sul Cancro-National Institute for Cancer Research and University of Genoa, Genoa, Italy
| | - Eunyoung Han
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Lukasz Matulewicz
- Department of Radiation Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
| | - Kai Schubert
- Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
| | - Ravishankar Chityala
- Department of Therapeutic Radiology, University of Minnesota, Minneapolis, Minnesota; Minnesota Super Computer Institute, University of Minnesota, Minneapolis, Minnesota
| | - Vaneerat Ratanatharathorn
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Koen Tournel
- Department of Radiotherapy, Universitair Ziekenhuis Brussel, Brussels, Belgium
| | - Jose A Penagaricano
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Sterzing Florian
- Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
| | - Marc-Andre Mahe
- Department of Radiation Oncology, Integrated Center of Oncology-René Gauducheau, Saint-Herblain Cédex, France
| | - Michael R Verneris
- Divisions of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
| | - Daniel J Weisdorf
- Department of Medicine, University of Minnesota, Minneapolis, Minnesota
| | - Renzo Corvo
- Department of Radiation Oncology, Instituto Nazionale per la Ricerca sul Cancro-National Institute for Cancer Research and University of Genoa, Genoa, Italy
| | - Kathryn E Dusenbery
- Department of Therapeutic Radiology, University of Minnesota, Minneapolis, Minnesota
| | - Guy Storme
- Department of Radiotherapy, Universitair Ziekenhuis Brussel, Brussels, Belgium
| | - Susanta K Hui
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota; Department of Therapeutic Radiology, University of Minnesota, Minneapolis, Minnesota.
| |
Collapse
|
48
|
Skórska M, Piotrowski T, Kaźmierska J, Adamska K. A dosimetric comparison of IMRT versus helical tomotherapy for brain tumors. Phys Med 2014; 30:497-502. [PMID: 24613513 DOI: 10.1016/j.ejmp.2014.02.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2013] [Revised: 02/10/2014] [Accepted: 02/12/2014] [Indexed: 10/25/2022] Open
Abstract
BACKGROUND AND PURPOSE Helical tomotherapy (HT) can deliver highly conformal, uniform doses to the target volume. However, HT can only be delivered in a coplanar mode. The purpose of this study was to perform a dosimetric comparison of HT versus coplanar (cIMRT) and non-coplanar (n-cIMRT) beam arrangements on a conventional linear accelerator in a diverse group of brain tumors. MATERIALS AND METHODS A total of 45 treatment plans were calculated retrospectively for 15 cases. For each case, 3 different delivery techniques (n-cIMRT, cIMRT and HT) were used. The treatment plans were compared using the parameters of the target coverage (conformity index; CI) and homogeneity (HI) for the planning target volume (PTV) and the maximum and mean doses for organs at risk (OARs). RESULTS Median HI and CI were the best for HT plans and the worst for cIMRT. The largest reduction of maximum dose for lenses and mean dose for both eyes was achieved for n-cIMRT plans. Mean dose for chiasm and the ipsilateral optic nerve were the lowest for HT. The contralateral optic nerve was most spared with n-cIMRT. For D1% in the brain stem, there was no significant difference between HT and the IMRT plans. CONCLUSIONS Both HT and n-cIMRT are capable of producing conformal and homogeneous treatment plans with a good sparing of OARs. However, due to the non-coplanar capabilities of IMRT, n-cIMRT led to a superior dose reduction to the lenses.
Collapse
Affiliation(s)
- M Skórska
- Department of Medical Physics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
| | - T Piotrowski
- Department of Medical Physics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland; Department of Electroradiology, University of Medical Sciences, Poznan, Poland
| | - J Kaźmierska
- Department of Electroradiology, University of Medical Sciences, Poznan, Poland; Department of Radiotherapy II, Greater Poland Cancer Centre, Poznan, Poland
| | - K Adamska
- Second Radiotherapy Ward, Greater Poland Cancer Centre, Poznan, Poland
| |
Collapse
|
49
|
Jank J, Kragl G, Georg D. Impact of a flattening filter free linear accelerator on structural shielding design. Z Med Phys 2014; 24:38-48. [DOI: 10.1016/j.zemedi.2013.05.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2012] [Revised: 05/16/2013] [Accepted: 05/17/2013] [Indexed: 10/26/2022]
|
50
|
Lissner S, Schubert K, Wiezorek T, Sterzing F, Herfarth K, Sroka-Perez G, Debus J. Investigations of peripheral dose for helical tomotherapy. Z Med Phys 2013; 23:324-31. [PMID: 23876598 DOI: 10.1016/j.zemedi.2013.06.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2012] [Revised: 02/14/2013] [Accepted: 06/14/2013] [Indexed: 11/19/2022]
Abstract
PURPOSE Whenever treating a patient with percutaneous radiotherapy, a certain amount of dose is inevitably delivered to healthy tissue. This is mainly due to beam's entry and exit in the region of the target volume. In regions distant from the target volume, dose is delivered by leakage from the MLC and head scatter from the accelerator head and phantom scatter from the target volume (peripheral dose). Helical tomotherapy is a form of radiation therapy with a uniquely designed machine and delivery pattern which influence the peripheral dose. The goal of this work was to investigate peripheral dose in helical tomotherapy. The experiments were used to establish a complex characterization of the peripheral dose. MATERIALS AND METHODS A 30*30*60cm(3) slab phantom and TLD-100 (Lithium fluoride) were used for the experiments. Treatment procedures were generated with the tomotherapy planning system (TPS). Additionally, procedures were created on the Operator Station of the tomotherapy system without a calculation of the dose distribution. The peripheral dose which was produced by a typical tomotherapy treatment plan was measured. Furthermore, these procedures were used to differentiate the parts of the peripheral dose in phantom scatter dose and head scatter and leakage dose. Additionally, the relation between peripheral dose and treatment time and between peripheral dose and delivered dose was investigated. Additionally, the peripheral dose was measured in an Alderson phantom. RESULTS Distances of 30cm or more resulted in a decrease of the peripheral dose to less than 0.1% of the target dose. The measured doses have an offset of approximately 1cGy in comparison to the calculated doses from the TPS. The separated head scatter and leakage dose was measured in the range of 1cGy for typical treatments. Furthermore, the investigations show a linear correlation between head scatter leakage dose and treatment time and between scatter dose parts and delivered dose. A peripheral dose of 0.28% of the target dose was measured in the Alderson phantom at a distance of 17.5cm from the edge of the target volume. CONCLUSIONS The peripheral dose delivered by a tomotherapy treatment is clinically unobjectionable. The measurements confirmed a linear correlation between head scatter and leakage and treatment time and between scatter dose and delivered dose.
Collapse
Affiliation(s)
- Steffen Lissner
- Department of Radiation Oncology, University Hospital Heidelberg, Germany.
| | | | | | | | | | | | | |
Collapse
|